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The mammalian circadian clock, found in virtually every cell, coordinates 
rhythmic expression to control the daily regulation of biological functions. These cell 
autonomous circadian clocks rely on a molecular feedback loop involving the 
heterodimeric transcription factor CLOCK:BMAL1 to activate the transcription of 
repressor elements Period (Per1/2) and Cryptochrome (Cry1/2). PER and CRY feedback 
to inhibit CLOCK:BMAL1’s transcriptional activation of this feedback loop, as well as 
expression of genes needed to regulate biological functions. However, recently a 
surprising disconnect has been found between CLOCK:BMAL1 genome-wide binding 
sites and CLOCK:BMAL1’s target genes expression. The goal of this research was to 
investigate the mechanisms of how the circadian clock controls transcription and how 
disruption of the circadian clock leads to diseases.  
To achieve this goal, we did a computational analysis of genome-wide sequencing 
datasets. We found that while CLOCK:BMAL1 promotes rhythmic nucleosome removal, 
this was not sufficient to activate these enhancers. Likely, these enhancers rely on 
cooperation of CLOCK:BMAL1 and the recruitment of ubiquitously expressed 
transcription factors, and not tissue-specific transcription factors to control transcription. 
These data were exemplified by analysis of how fasting effects the amplitude of 
rhythmically transcribed CLOCK:BMAL1 target genes, but not the expression of 
CLOCK:BMAL1. Altogether this suggest that CLOCK:BMAL1 creates transcriptionally 




provide a new framework of how disruption of the circadian clock leads to pathological 
conditions.  
To study disruption of the circadian clock we used a shift work model in rats to 
discover if this can emulate cardiovascular disease. Additionally, since temporal food 
consumption has been found to have preventive effect on shift work induced metabolic 
disorders, we restricted food intake to the night for a group of shift working rats. We found 
that five weeks of shift work in rats causes a significant increase in collagen deposition in 
the heart and that gene expression for shift work rats that had their food restricted, 
exhibited a significant up-regulation of profibrotic genes. Altogether, this suggests that 
five weeks of shift work in rats is capable of inducing cardiovascular disease through up-
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
The autonomous mammalian circadian clock 
Living organisms have many physiological activities that show rhythmic changes within a 
period of approximately 24 hours, even under constant environmental conditions or without any 
external time cues. These daily 24-hour variations are called circadian rhythms and are generated 
by a cell-autonomous time-measuring system called the circadian clock 1. Additionally, the 
circadian clock can also be entrained by zeitgebers (German word for “time giver” or 
“synchronizer”), which are environmental cues that synchronize the circadian clock. It is a 
convention in the field of circadian rhythms to refer to light on as Zeitgeber (ZT) 0 and light off 
as ZT12. There are many additional examples of zeitgebers such as light, temperature, social 
interactions, exercise, and eating and drinking. This ability for organisms to tell time allows for an 
organism to anticipate environmental changes and to adapt to many parameters such as nutrient 
availability and predation 2. Circadian clocks can be found in a wide variety of organisms, from 
cyanobacteria and fungi to higher eukaryotic plants and mammals, and dysregulation of the clock 
disrupts biochemical and metabolic pathways which results in diseases, such as diabetes or cancer 
3,4.  
 
Mammalian molecular circadian clock is controlled by a negative feedback loop 
 In mammals, the master clock resides in the hypothalamic suprachiasmatic nucleus (SCN) 




ubiquitous and are found in almost every cell 5. Peripheral clock cells can also respond to inputs 
individually depending on entrainment signals and will control different physiological outputs. 
However, they still receive some inputs from the SCN to coordinate biological processes as a 
whole 6. These central and peripheral clocks coordinate clock genes that form a transcription/ 
translation-based negative-feedback loop to generate the 24-hour molecular clock 7,8. This feeding 
back loop is initiated by heterodimeric basic helix-loop-helix (bHLH)-PAS positive transcription 
factor CLOCK:BMAL1. This heterodimeric transcription factor binds to CACGTG E-box or E-
box-like sequences to promote transcription activation of negative regulatory genes, such as Period 
(Per1 and Per2) and Cryptochrome (Cry1 and Cry2) genes. These PER and CRY proteins form a 
complex, enter the nucleus, and bind to CLOCK:BMAL1 to inhibit CLOCK:BMAL1’s 
transcriptional activation 9-11. The current model in the field, illustrated in Figure I-1, assumes that 
CLOCK:BMAL1 binds rhythmically to negative regulatory genes, as well as other rhythmically 
expressed genes, and recruits transcriptional machinery to promote rhythmic transcription 7. This 
model, however, has been recently challenged by the finding that the majority of CLOCK:BMAL1 
target genes are not rhythmically expressed 12. Additionally, that CLOCK:BMAL1 directly 
regulates their DNA binding sites by opening the chromatin and thus indirectly regulating 




Figure I-1 Current Model of the Circadian Clocks Positive and Negative Feedback Loops and Rhythmic Gene 
Expression. 
CLOCK and BMAL1 form a heterodimer and bind to E-boxes initiating transcription of their negative regulatory elements Cry and Per genes. PER 
and CRY from a complex and re-enter the nucleus and inhibit CLOCK:BMAL1 activation. CLOCK:BMAL1 also initiates rhythmic gene expression 
of other clock controlled genes. This rhythmic gene expression is illustrated in a heatmap. Highly expressed genes are shown in yellow and lower 





Mammalian transcription regulation 
 Transcription in mammals is a multistep process that starts with initiation of 
transcription by RNA polymerase II (RNA pol II) at specific DNA sites called promoters. 
Messenger RNA (mRNA) is produced after transcription elongation and termination of RNA Pol 




nucleus for translation to occur 14. While all these steps can be specifically regulated, transcription 
initiation is generally the main step controlling gene expression 15.  
Chromatin is a dynamic structure that is not only in charge of packaging the entire 
eukaryotic genome but also regulates the accessibility of the DNA for transcription. A nucleosome 
at the transcription start site can inhibit the ability of Pol II and transcription 16. There are four core 
histone variants that make up a nucleosome, H3, H2A, H2B, and H1 17. These histone variants can 
vary depending on the needs of the cell. One of the ways the cell regulates DNA accessibility is 
by facilitating histone exchanges by incorporation of histone variants. Histone variants such as 
H3.3 and H2A.Z are modifications of H3 and H2A, and have been correlated with active 
transcription. Histone post-translational modifications such as acetylation, methylation, 
ubiquitylation, and sumoylation can also be used to regulate chromatin structure and transcription. 
These post-translational modifications affect nucleosome stability by interacting with the chemical 
structures inside the nucleosome, neighboring nucleosomes, or histone-DNA interactions 17. For 
example, H3K9 acetylation is associated with active promoters and H3K27 acetylation is 
associated with active enhancers 18,19. Such modifications can result in open or closed chromatin 
which affects the binding of transcription factors (TFs) and the machinery needed for transcription. 
TFs can also bind and alter the chromatin landscape, making it more permissible for transcription 
by competing with nucleosomes for the accessibility to the DNA 20.  
For transcription to occur, TFs typically bind to enhancers and promoters found in open 
chromatin, and this initiates the recruitment of other TFs, the pre-initiation complex (PIC), and the 
Mediator 14,21. The PIC is made up of general transcription factors (GTFs) TFIIB, TFIID, TFIIE, 
TFIIF and TFIIH, as well as RNA Pol II (Pol II). The GTFs and Pol II assemble at promoters and 




II activity 14. This Pol II activity is generally paused until the Pol II C-terminal domain (CTD) 
serine5 is phosphorylated and the DNA in the promoter region is unwound and opened by TFIIH 
22. Meyer et al., 2010 also found that TFIIH phosphorylation of the CTD of Pol II was completely 
dependent on the Mediator, suggesting that the PIC, the Mediator, and TFIIH work together to 
control Pol II and transcription.  
The Mediators basic function is to communicate regulatory signals from TFs and the PIC 
directly to RNA Pol II. However, the exact mechanism by which this occurs is still unknown. The 
core Mediator complex is generally made up of 26 proteins and the composition of the Mediator 
complex dictates what function the Mediator will have on transcription 21,23. For example, the 
Med12 subunit has been associated with gene repression by recruiting the repressive CDK8 
subcomplex to the PIC and Pol II 24 and the Med1 subunit has been associated with gene activation 
and recruitment of the PIC and Pol II 23. The Mediator has also been found to be important for the 
organization of gene looping, which enables the coordination and regulation of gene expression, 
such that it connects enhancers to the promoter and thus regulates initiation, elongation, and 
chromatin architecture 21. Additionally an essential component for the coordinating transcription 
activation of gene networks is this three-dimensional organization of the genome or gene looping 
25. Previous studies have shown the promoter of one gene interacts not only with enhancers that 
can be megabases away, but other gene promoters. These interactions are not random and appear 
to be occurring to promote coordinated gene expression for related biological functions 26-28. The 
chromatin looping landscape appears to involve many proteins, but some of the core proteins are 
CCCTC-binding factor (CTCF), cohesion loading factor Nipbl, Cohesin, and the Mediator 29,30. 
CTCF binds to the DNA and has been associated with mediating long-range interactions by 




active and silent domains 26,31. Cohesion loading factor Nipbl helps load cohesion on to the DNA 
and helps to facilitate the regulation of gene expression by associating with the Mediator complex 
23,32. For this reason, the three-dimensional organization, the Mediator complex, the PIC, and 
possibly other TFs may promote interactions between gene promoters and enhancers and maintain 
the chromatin landscape.  
 
Dysregulation of the circadian clock’s coordination of biological processes 
 The circadian clock coordinates transcription to activate biological processes needed 
throughout the 24-hour day. However, many modern day lifestyles now alter the zeitgebers that 
are needed to coordinate the circadian clock 33. For example, there are many nontraditional work 
schedules that are becoming increasingly more frequent to meet the high demands of today’s 
industries 34. Many of these schedules require people to work during the night when the circadian 
clock is coordinating inactivity.  
 Shift work or any nontraditional work schedules that occur outside the typical working 
hours of 9am to 5pm have been correlated with an increased risk of pathological diseases 35. 
Approximately 15-30% of the European and American work force do some form of shift work and 
despite the ability for these workers to force themselves to stay awake and function on the job, a 
majority of shift workers do not exhibit a shift in their circadian clock functions  33,34. Working at 
night has been found to alter food consumption, rhythms in body temperature, and rhythms in 
hormones 36,37.  
 The circadian clock in mammals is a hierarchical collection of cell-autonomous biological 
clocks that are coordinated by the SCN 5. This SCN is directly entrained by light from photo-




circadian clocks to control overt rhythms of body temperature, feeding behavior, and hormone 
release 33. This entrainment by light means that the SCN can be reset with light at night. 
Furthermore, even low levels of light at night have been shown to have the ability to reset the 
circadian clock in the SCN, suggesting that even the use of low levels of artificial light used at 
home may alter the circadian clock 33. This desynchronization between light at night and the phase 
of the SCN’s circadian clock has been hypothesized to lead to metabolic diseases, cardiovascular 
disease, cancer, and an increased risk of mortality(Figure I-2) 33.  






Figure I-2 Current Model of How Disruption of the Circadian Clock Leads to Internal Desynchronization 
Cell autonomous circadian clocks, found throughout the body are coordinated by zeitgebers and the SCN. Shift work affects daily rhythms of food 





Shift workers have an increased risk of cardiovascular disease  
A meta-analysis on 17 studies found that shift workers had a 40% increased risk of 
cardiovascular disease compared to day workers 35. However, the exact mechanisms between how 
this desynchronization of the circadian clock and shift work and how it causes an increased risk of 
cardiovascular disease is unknown 35,39-41. Cardiovascular disease includes many different types of 
pathologies found in the heart and in general includes any diseased blood vessels, structural 
problems, and blood clots 42. Many studies have been done to try and decipher the molecular 
mechanisms that occur to lead to cardiovascular disease 39,42-44. The primary risk factors that have 




a mismatch in eating time and the enzymatic activity controlled by circadian rhythms. This has 
been found to be correlated with an increase in cholesterol levels which can lead to hypertension 
and excess stress on the heart 39,45,46. Smoking has been highly correlated with cardiovascular 
disease and furthermore shift workers have been noted to smoke more than day workers 39. 
Smoking has also been highly correlated with coronary heart disease by damaging the lining of 
arteries, increasing in atheroma (fatty material) and increasing blood pressure 39,45,47. Another 
known consequence to shift work is the stress of interfering with family or social interactions. 
Shift work generally tends to reduce the time available for social interaction and thus can lead to 
social isolation. This stress has been associated with increased cholesterol levels and myocardial 
infarction. However, the mechanisms by which this behavioral stress impacts physiology are 
incredibly hard to study 39,48,49.  
Many different studies have tried to identify the biological mechanisms that occur to cause 
cardiovascular disease. It is suggested that cardiovascular disease occurs in two parts and can be 
identified with biomarkers. The first part is a slow buildup of plaque in the arteries, called 
atherosclerosis 39. This has been identified by looking at cholesterol, triglyceride, and 
apolipoproteins circulation in the blood. The second part is thrombosis and has been identified by 
looking at coagulation and fibrinolytic proteins 39. The last major biomarkers used to diagnose 
cardiovascular disease are high blood pressure and electrocardiograph which have been used in 
particular to diagnose hypertrophy in the heart 39,43. Studies on shift work have had mixed results 
on whether the increased risk of cardiovascular disease is associated with an increase in these 






Pathological cardiac remodeling 
 After cardiovascular disease manifests it is always associated with an increase in interstitial 
fibrosis 44. This increase in activation and expansion of cardiac fibroblast alters the extracellular 
matrix of the heart by increasing collagen levels and other extracellular matrix proteins 44,50. One 
of the main pathways that is responsible for activating proliferation of fibroblasts and extracellular 
matrix remodeling is the transforming growth factor beta (TGF-β) pathway  51,52. This pathway is 
essential in promoting extracellular matrix deposition by increasing collagen and fibronectin 
synthesis, by inhibiting expression of matrix metalloproteinases (MMPs) and matrix degradation 
through activation of tissue inhibitors of metalloproteinases (TIMPs) 52,53.  
The TGF-β pathway is also considered a master switch in that it also activates and 
cooperates multiple other signaling pathways, such as epidermal growth factor receptor (ErbB), 
mammalian target of rapamycin (mTOR), Mitogen-activated protein kinase kinase (MEK), protein 
kinase B (AKT) and insulin receptor tyrosine kinase (INSR) pathways (Figure I-3) 51. The TGF-β 
pathway does this by phosphorylating SMAD2/3 which bind to SMAD4 causing it to translocate 
to the nucleus to activate many profibrotic genes and ErbB ligands needed to activate the ErbB 
pathway 44,51. The ErbB pathway is essential for cardiac paracrine mediator of cell to cell 
interactions to maintain cardiac function and activates a signaling cascade needed to adapt to stress 
in the myocardium 54. SMAD independent pathways for TGF- β include interactions through 
phosphoinositide 3-kinase (PI3K), AKT, and mTOR which are primarily responsible for changes 
in translational and hypertrophy found in heart failure 55. TGF- β also activates MEK which 
activates extracellular signal-regulated kinase (ERK) and regulates transcription needed for 




of interacting with PI3K and has been shown to be hyperactive in pathological hypertrophic hearts 




Figure I-3 Model of Signaling Pathways Regulating Cardiac Fibrosis. 
Activation of TGF-β receptor activates the canonical SMAD pathway which in turn activates expression of profibrotic genes. TGF-β receptor non-
canonical activation results in activation of MEK and PI3K. MEK activates ERK and causes ERK translocate to the nucleus to activate transcription. 











Virtually every mammalian cell harbors a molecular circadian clock that enables biological 
functions to adapt to the daily environmental variation. These mammalian clocks rely on the 
rhythmic recruitment of the heterodimeric transcription factor CLOCK:BMAL1 to their target 
genes to coordinate the rhythmic expression of 10-15% of the transcriptome. This rhythmic 
expression of the transcriptome promotes the activation of key biochemical and metabolic 
pathways needed for daily adaptation to the environment 7,56,57.  
The recent characterization of CLOCK:BMAL1 DNA binding sites at the genome-wide 
level revealed that the majority of their target genes are not rhythmically expressed, suggesting 
that CLOCK:BMAL1 rhythmic DNA binding alone does not directly activate transcription and 
that other factors contribute to transcriptional output 12. These other factors may include 
transcription activation hallmarks like nucleosome positioning, histone modifications, 
transcription factors and RNA polymerase II (Pol II) recruitment to DNA.  
The first aim of this study is to discover the disconnect that is occurring between the 
homogenous binding of CLOCK:BMAL1 and its heterogeneous output. We performed a meta-
analysis on genome wide datasets and found that CLOCK:BMAL1 are not sufficient to generate 
transcriptionally active enhancers and that ubiquitously expressed transcription factors are likely 
contributing to CLOCK:BMAL1 transcriptional output. This suggests that CLOCK:BMAL1 
promote transcriptionally permissive chromatin landscapes allowing for the binding of other 
transcription factors to activate transcription when changes occur environmentally or pathological 
conditions arise.  
The second aim is to investigate what happens when work is done out of synchronization 




diseases, such as cancer and metabolic disorders 3,4. Furthermore, shift work has also been reported 
to be associated with many different pathologies, including metabolic disorders, cancer, and 
cardiovascular disease 35,39,58,59. The mechanisms of how shift work causes these different 
pathologies is unknown, however many studies have suggested that it is a desynchronization of 
working out of sync with the circadian clock 35,40.  
To address the issue of how or if shift work and desynchronization of the circadian clock 
is causing cardiovascular disease, we conducted RNA-Seq and Picrosirius Red staining on hearts 
of rats that were forced to do shift work. We found that five weeks of shift work was sufficient to 
increase collagen deposition. Furthermore, we found that time of eating did not inhibit collagen 
deposition caused by shift work. Surprisingly, we did find that rats forced to do shift work but only 
allowed to eat at night had a significant change in gene expression compared to rats forced to do 
shift work but allowed to eat ad libitum and control rats. Our analysis suggests that five weeks of 
shift work is capable of significantly increasing collagen production in the heart and suggests a 






CHAPTER II  




The mammalian circadian clock relies on the transcription factor CLOCK:BMAL1 to 
coordinate the rhythmic expression of 15% of the transcriptome and control the daily regulation 
of biological functions. The recent characterization of CLOCK:BMAL1 cistrome revealed that 
although CLOCK:BMAL1 binds synchronously to all of its target genes, its transcriptional output 
is highly heterogeneous. By performing a meta-analysis of several independent genome-wide 
datasets, we found that the binding of other transcription factors at CLOCK:BMAL1 enhancers 
likely contribute to the heterogeneity of CLOCK:BMAL1 transcriptional output. While 
CLOCK:BMAL1 rhythmic DNA binding promotes rhythmic nucleosome removal, it is not 
sufficient to generate transcriptionally active enhancers as assessed by H3K27ac signal, RNA 
Polymerase II recruitment, and eRNA expression. Instead, the transcriptional activity of 
CLOCK:BMAL1 enhancers appears to rely on the activity of ubiquitously expressed transcription 
factors, and not  tissue-specific transcription factors, recruited at nearby binding sites. The 
contribution of other transcription factors is exemplified by how fasting, which effects several 
transcription factors but not CLOCK:BMAL1, either decreases or increases the amplitude of many 
rhythmically expressed CLOCK:BMAL1 target genes.  
 
_________________________________________________ 
*Reprinted with permission from “Regulation of circadian clock transcriptional output by CLOCK:BMAL1” by 





Together, our analysis suggests that CLOCK:BMAL1 promotes a transcriptionally permissive 
chromatin landscape that primes its target genes for transcription activation rather than directly 
activating transcription, and provides a new framework to explain how environmental or 
pathological conditions can reprogram the rhythmic expression of clock-controlled genes.  
 
Introduction 
Virtually every mammalian cell harbors a circadian clock that regulates rhythmic gene 
expression to enable biological functions to occur at the most appropriate time of day. Circadian 
clocks rely on transcriptional feedback loops which are initiated in mammals by the heterodimeric 
transcription factor CLOCK:BMAL1 for review, 60. CLOCK:BMAL1 rhythmically binds to DNA 
to activate the rhythmic transcription of the core clock genes Period (Per1, Per2, Per3), 
Cryptochrome (Cry1 and Cry2), Rev-erb (Rev-erbα and Rev-erbβ) and Ror (Rorα, Rorβ and Rorγ). 
Upon expression and maturation, PERs and CRYs form a repressive complex that rhythmically 
inhibits CLOCK:BMAL1-mediated transcription first on-DNA and then off-DNA 7,61-63. 
Furthermore, REV-ERBs and RORs rhythmically regulate Bmal1 expression by repressing or 
activating its transcription, which promotes robustness of circadian oscillations 64,65. In addition to 
activating the rhythmic transcription of core clock components, CLOCK:BMAL1 also regulates 
rhythmic expression of thousands of clock-controlled genes to generate oscillations in 
biochemistry, physiology and behavior, and thus control the rhythmic organization of most 
biological functions 56,57,66.  
Characterizing the mechanisms through which CLOCK:BMAL1 regulates expression of 
its target genes has largely been carried out by determining how CLOCK:BMAL1 regulates the 




site of albumin promoter binding protein). Results from many laboratories show that the rhythmic 
binding of CLOCK:BMAL1 to e-boxes located in core clock gene promoters is necessary and 
sufficient for rhythmic transcription 62,63,67-69. Upon DNA binding during the light phase, 
CLOCK:BMAL1 promotes chromatin modifications by recruiting histone-modifying enzymes to 
core clock gene promoters and enhancers. These enzymes include the histone acetyltransferases 
p300 and CBP, which mediate the acetylation of H3K9 and H3K27, and the histone 
methyltransferases MLL1 and MLL3 (Myeloid/Lymphoid Or Mixed-Lineage Leukemia 1 and 3), 
which promote the tri-methylation of H3K4 7,70-75. CLOCK:BMAL1 rhythmic DNA binding was 
also recently shown to promote rhythmic nucleosome removal, thereby generating a chromatin 
landscape that is favorable for the binding of other transcription factors at its enhancers 13. Finally, 
CLOCK:BMAL1 recruits transcriptional co-activators, including components of the mediator 
complex and RNA Polymerase II (Pol II) to initiate core clock gene transcription 7,76,77. During the 
repression phase in the early night, binding of the PER/CRY complex to DNA-bound 
CLOCK:BMAL1 is accompanied by the co-recruitment of histone deacetylases and demethylases 
and the removal of the H3K9ac, H3K27ac and H3K4me3 marks 75,78-82. While these mechanisms 
are required for CLOCK:BMAL1-mediated transcription activation of core clock genes, it still 
remains unclear if the same mechanisms regulate the rhythmic expression of clock-controlled 
genes. 
The recent characterization of CLOCK and BMAL1 mouse liver cistromes revealed that 
although CLOCK:BMAL1 binds synchronously during the middle of the day to thousands of 
enhancers and promoters, the transcription of its target genes is highly heterogeneous 7,12,83,84. 
Indeed, not all CLOCK:BMAL1 target genes are rhythmically expressed, and a large fraction of 




CLOCK:BMAL1 DNA binding 12. These data therefore suggest that the mechanisms by which 
CLOCK:BMAL1 regulates transcription of core clock genes differs from the regulation of other 
clock-controlled genes, and that additional mechanisms account for the activation of rhythmic gene 
expression by the circadian clock. 
To uncover these mechanisms and to delineate the transcriptional logic underlying 
CLOCK:BMAL1 heterogeneous transcriptional output, we performed a meta-analysis of genome-
wide datasets investigating the molecular events occurring at CLOCK:BMAL1 DNA binding sites, 
including CLOCK:BMAL1 rhythmic DNA binding, epigenetic modifications and transcription 
activation. Our analysis reveals that while CLOCK:BMAL1 DNA binding is sufficient to 
decondense the chromatin and prime its enhancers for transcriptional activation, it is not sufficient 
to generate transcriptionally active enhancers. Our results also indicate that many transcription 
factors bind to CLOCK:BMAL1 enhancers, and their recruitment likely contributes to 
CLOCK:BMAL1 clock-controlled transcriptional output. Altogether, our data support that 
CLOCK:BMAL1 regulation of clock-controlled gene expression relies on the cooperation between 
CLOCK:BMAL1 and other transcription factors. Furthermore, our data also suggest that a major 
role of CLOCK:BMAL1 is to generate a permissive chromatin landscape to rhythmically prime 
its enhancers for the recruitment of other transcription factors, rather than directly promoting 










CLOCK:BMAL1 transcriptional output is heterogeneous 
To characterize the mechanisms by which CLOCK:BMAL1 regulates the transcriptional 
activity of its target genes at the genome-wide level in the mouse liver, we first generated a list of 
high-confidence CLOCK:BMAL1 DNA binding sites by determining the overlap between 
CLOCK and BMAL1 ChIP-Seq peaks in the mouse liver 7. This analysis resulted in a list of 3217 
CLOCK:BMAL1 binding sites, of which 2458 peaks can be assigned to a direct target gene (i.e., 
a CLOCK:BMAL1 peak located between -10kb of a target gene transcription start site and +1kb 









Figure II-1 Assignment of CLOCK:BMAL1 DNA Binding Sites to Their Target Gene Transcriptional Output 
in the Mouse Liver. 
Flowchart illustrating the procedure used to identify CLOCK:BMAL1 target genes and to determine their transcriptional output in the mouse liver. 
See Methods section for details. Briefly, publicly available lists of CLOCK and BMAL1 DNA binding sites from 7 were compared and the 
overlapping CLOCK and BMAL1 peaks were identified as CLOCK:BMAL1 DNA binding sites (BMAL1 peak coordinates were kept for 
downstream analysis). Of the 3217 identified CLOCK:BMAL1 peaks, 2458 were assigned to a target gene (peak located by HOMER software 
between -10kb of a gene transcription start site and +1kb of a gene transcription termination site). The remaining 759 peaks were listed as intergenic. 
The list of 2458 CLOCK:BMAL1 peaks was then parsed based on their target genes transcriptional output using our publicly available Nascent-
Seq analysis of rhythmic transcription in the mouse liver 12. 329 CLOCK:BMAL1 peaks were found to target rhythmically transcribed genes in the 
mouse liver. Of these, 205 peaks were found to target rhythmically transcribed genes with a peak of transcription coinciding with CLOCK:BMAL1 
rhythmic DNA binding (from ZT02 to ZT12; in-phase rhythmic transcriptional cyclers or Rinφ), whereas 124 peaks were targeting genes with a 
peak of rhythmic transcription out-of-phase with CLOCK:BMAL1 DNA binding (from ZT12 to ZT02; out-of-phase transcription cyclers or Ro/φ). 
A total of 916 CLOCK:BMAL1 peaks were assigned to genes exhibiting an arrhythmic nascent RNA profile. To ensure that these target genes are 
“true” arrhythmically expressed target genes, the list was further filtered by removing those exhibiting rhythmic mRNA expression using the dataset 
from 12, resulting in a final list of 654 CLOCK:BMAL1 peaks targeting arrhythmically transcribed genes. Finally, the remaining CLOCK:BMAL1 
peaks were assigned to genes expressed below the expression threshold set to determine rhythmic gene expression. Because this threshold is set to 
call rhythmically expressed genes with high confidence rather than calling “true” non-expressed genes, we further filtered this list of peaks by 
removing genes exhibiting an averaged signal greater than 1 read/bp for the 12 time points of the Nascent-Seq dataset. This filtering resulted in a 
list of 291 CLOCK:BMAL1 peaks targeting non-expressed genes. The list of the 3217 CLOCK:BMAL1 peaks parsed based on their target gene 






To determine the extent to which rhythmic CLOCK:BMAL1 DNA binding contributes to 
rhythmic transcription activation at the genome-wide level, we used a public mouse liver Nascent-
Seq dataset that characterized the levels of nascent RNA expression over the course of a 24-hr day 
12. A Nascent-Seq dataset was preferred over RNA-Seq because nascent RNA expression directly 
reflects transcription activation, and is unaffected by the post-transcriptional regulations that 
contribute to rhythmic mRNA expression in the mouse liver 7,12,85. We found that only a small 
fraction of CLOCK:BMAL1 target genes are rhythmically transcribed (~26%; Figure II-1). 
Noticeably, not all rhythmic target genes are transcribed during the day, i.e., coincidently with 
rhythmic CLOCK:BMAL1 DNA binding (ZT02-ZT12). Indeed, 38% of the rhythmic 
CLOCK:BMAL1 target genes exhibit a peak of transcription between ZT12 and ZT02, out-of-
phase with the rhythmic DNA binding of CLOCK:BMAL1 (n = 124 CLOCK:BMAL1 peaks) 
(Figure II-2 A-C; Figure II-1). Importantly, our analysis also reveals that the majority of 
CLOCK:BMAL1 direct target genes are either arrhythmically transcribed (AR; n = 654 
CLOCK:BMAL1 peaks) or not expressed (NE; n = 291 CLOCK:BMAL1 peaks) (Figure II-2 A-











Figure II-2 Mouse Liver CLOCK:BMAL1: Transcriptional Output is Heterogeneous. 
A, B. Mouse liver BMAL1 (blue, A) and CLOCK (green, B) ChIP-Seq peaks from Koike et al., 2012 were mapped to their target genes and parsed 
based on their transcriptional output (Nascent-Seq from Menet et al., 2012, C). Each dot represents the phase of maximal DNA binding, and the 
ChIP-Seq signal is displayed using different shades of color to illustrate differences in binding intensity. C. Heatmap representation of the Nascent-
Seq signal of direct CLOCK:BMAL1 target genes classified based on their transcriptional output in the mouse liver. Each lane represents the 
Nascent-Seq signal of a gene corresponding to the CLOCK and BMAL1 peaks in A and B. Nascent-Seq signal was ordered based on the phase of 
nascent RNA oscillations for the in-phase and out-of-phase transcriptional cyclers, and based on BMAL1 ChIP-Seq signal for arrhythmically 
transcribed genes. No heatmap could be generated for the non-expressed genes because of the lack of nascent RNA expression. D. Nascent RNA 
expression, calculated as reads/bp, for each of the 4 CLOCK:BMAL1 transcriptional output group (Rinφ: in-phase transcriptional cyclers; Ro/φ: 
out-of-phase transcriptional cyclers; AR: arrhythmically transcribed target genes; NE: non-expressed target genes) . Groups with different letters 
are significantly different (Kruskal-Wallis test; p < 0.05). E. Phase of maximal BMAL1 (left) and CLOCK (right) rhythmic DNA binding for each 
of the 4 CLOCK:BMAL1 transcriptional output categories. Groups with different letters are significantly different (Kruskal-Wallis test; p < 0.05). 
F. BMAL1 (top) and CLOCK (bottom) ChIP-Seq signal for each of the 4 CLOCK:BMAL1 transcriptional output groups. Signal is also displayed 
for the Rinφ and Ro/φ groups after removal of the ChIP-Seq signal at peaks targeting core clock genes. Groups with different letters are significantly 
different (Kruskal-Wallis test; p < 0.05). G. Location of CLOCK:BMAL1 peaks within gene loci for each of the 4 CLOCK:BMAL1 transcriptional 
output groups. TSS (transcriptional start site; +/- 1kb from annotated TSS); Gene body: + 1kb from TSS to + 1kb from transcription termination 
site; Extended promoter: - 10 kb to - 1 kb from the annotated TSS. Numbers correspond to the percentage and numbers of peaks (outside and inside 
the pie chart, respectively) within each location for each group. * denotes a significant difference in the distribution of peaks between the AR and 






To determine if this result may be due to comparing samples collected in constant darkness 
(ChIP-Seq) and in a light:dark (LD) cycle (Nascent-Seq), we also analyzed a mouse liver BMAL1 
ChIP-Seq rhythm performed under LD condition 83. BMAL1 binding phase and ChIP-Seq signal 
under LD condition both exhibit a remarkably high level of similarity to those under DD 
conditions, and this even for the AR or NE target genes (Figure II-3). This therefore suggests that 
the large number of arrhythmically transcribed or not expressed CLOCK:BMAL1 target genes is 
not a consequence of using datasets generated under different lighting conditions. Taken together, 
these results indicate that the mechanisms underlying CLOCK:BMAL1-mediated rhythmic 
transcription of core clock genes (i.e., Per1, Per2, Per3, Cry1, Cry2, Rev-erbα, Rev-erbβ and Dbp) 
are not prevalent at the genome-wide level. They also suggest that the rhythmic recruitment of 
CLOCK:BMAL1 at its target gene promoters and enhancers is not sufficient to activate 














Figure II-3 Effect of LD vs. DD Lighting Conditions on BMAL1 Rhythmic DNA Binding. 
Mouse liver BMAL1 ChIP-Seq datasets performed in mouse exposed to LD12:12 (Rey et al., 2011) or constant darkness (DD, Koike et al., 2012) 
were compared to determine if the lighting conditions (LD vs. DD) impact BMAL1 rhythmic DNA binding phase and signal. A. Correlation between 
BMAL1 ChIP-Seq signal in LD and DD for each of the 4 CLOCK:BMAL1 transcriptional output categories (rhythmic-in-phase (Rinφ, red); 
rhythmic out-of-phase (Ro/φ, orange); arrhythmic (AR, black); and non expressed (NE, grey) target genes). Peaks targeting core clock genes are 
depicted with an open circle. B. Correlation between the phase of BMAL1 DNA binding in LD and DD for each of the 4 CLOCK:BMAL1 
transcriptional output categories. C. Correlation between the phase of BMAL1 DNA binding in LD and DD for all 3217 CLOCK:BMAL1 ChIP-
Seq peaks from the Koike et al., 2012 dataset (see methods section for details). ChIP-Seq peaks were classified based on BMAL1 ChIP-Seq signal 
from Koike et al., 2012, and divided into 4 equal size quartiles. Peaks with higher ChIP-Seq signal display a better phase correlation in BMAL1 







CLOCK:BMAL1 heterogeneous transcriptional output is not mediated by differences in 
CLOCK:BMAL1 DNA binding 
To investigate the mechanisms underlying CLOCK:BMAL1 heterogeneous transcriptional 
output, we first examined if differences in the phase, intensity or location of CLOCK:BMAL1 
DNA binding might explain the differences in transcription activation. The phase of 
CLOCK:BMAL1 DNA binding was found to be indistinguishable between all four transcriptional 
output categories, as both CLOCK and BMAL1 rhythmically bind to DNA with a peak between 
ZT3 and ZT9 for almost all target genes (Figure II-2 A, B, E). We then used CLOCK and BMAL1 
ChIP-Seq signal as a readout to determine DNA binding intensity, and found that both CLOCK 
and BMAL1 ChIP-Seq signals are significantly higher at DNA binding sites targeting the in-phase 
transcriptional cyclers (Rinφ) when compared to peaks targeting the 3 other groups (out-of phase 
cyclers, arrhythmically expressed and non-expressed target genes) (Figure II-2 A, B, F; Kruskal-













Remarkably, the binding intensity of CLOCK and BMAL1 at non-expressed target genes (NE) is 
similar to the binding intensity observed at the out-of-phase transcriptional cyclers (Ro/φ) and 
arrhythmically transcribed (AR) target genes, suggesting that CLOCK:BMAL1 DNA binding 
alone does not directly activate transcription at most of its target genes (e.g., comparisons between 
Figure II-2 D and F). To verify that these results are not due to the cut-offs we used to partition 
CLOCK:BMAL1 transcriptional output, we performed similar analyses using direct correlations 
between BMAL1 or CLOCK ChIP-Seq signal and the phase of rhythmic transcription, as well as 
by partitioning rhythmic target genes in five groups of equal sizes. These analyses confirmed our 
results (Figure II-4 and Figure II-5). While rhythmically transcribed target genes peaking from 
ZT5 to ZT13 exhibit higher BMAL1 and CLOCK ChIP-Seq signal, no differences in DNA binding 
signal were observed between the rhythmically expressed targets peaking from ZT13 to ZT5 and 















Figure II-4 Analysis of BMAL1 and CLOCK ChIP-Seq Signal Based on the Phase of Target Gene 
Transcription.  
A. Analysis of BMAL1 ChIP-Seq signal from Koike et al. (2012) at CLOCK:BMAL1 peaks targeting rhythmically transcribed genes (RG), 
arrhythmically transcribed genes (AR) or not transcribed genes (NE). Peaks targeting rhythmic targets are binned in five groups of equal size for 
either all peaks (n = 329; groups RG1 to RG5), or those targeting non-core clock genes only (n = 307; groups RG1’ to RG5’). Data are represented 
as boxplots for each group and time points, and the thick line displays CLOCK:BMAL1 DNA binding rhythm based on the median of ChIP-Seq 
signal. Statistical analysis was performed by Kruskal-Wallis non-parametric test, and pair-wise post-hoc analyses are displayed for each of the six 
time points using color-coding of the p-values. B. Phases of nascent RNA expression of rhythmically transcribed CLOCK:BMAL1 target genes 
are displayed for either all rhythmic target genes (left, groups RG1 to RG5), or only non-core clock rhythmic target genes (right, groups RG1’ to 
RG5’). Nascent RNA expression was retrieved from Menet et al., 2012. C. Analysis of CLOCK ChIP-Seq signal from Koike et al. (2012) at 
CLOCK:BMAL1 peaks was performed as for BMAL1 ChIP-Seq signal in A. D. Nascent RNA expression of rhythmically transcribed 
CLOCK:BMAL1 is displayed for either all rhythmic targets (groups RG1 to RG5), or for non-core clock target genes (groups RG1’ to RG5’), as 
well was for arrhythmically transcribed target genes (AR), or non-expressed target genes (NE). Groups with different letters are significantly 








In addition, we did not find any significant correlation between either CLOCK or BMAL1 
ChIP-Seq signals and the phase of DNA binding or the phase of rhythmic transcription (Figure 
II-5). Because CLOCK:BMAL1 peaks targeting core clock genes are enriched in the Rinφ and 
Ro/φ groups and exhibit higher ChIP-Seq signal than clock-controlled (output) genes, we also 
compared CLOCK and BMAL1 ChIP-Seq signals between groups after removing peaks targeting 
the core clock genes (i.e., comparing clock-controlled genes only). Whereas BMAL1 ChIP-Seq 
signal intensity was still significantly higher at the Rinφ target genes compared to the three other 
groups, CLOCK DNA binding intensity was similar between all 4 groups (Figure II-2 F). Our data 
therefore indicate that while higher BMAL1 DNA binding signal may contribute to Rinφ 
transcription, the different transcriptional output of CLOCK:BMAL1 target genes cannot be 















Figure II-5 Correlation Analysis between CLOCK:BMAL1 ChIP-Seq Signal and CLOCK:BMAL1 Target 
Genes Nascent RNA Expression. 
A. Correlation between BMAL1 and CLOCK ChIP-Seq signal at CLOCK:BMAL1 ChIP-Seq peaks in the mouse liver from Koike et al., 2012 
datasets, parsed based on the transcriptional output of CLOCK:BMAL1 target genes (in-phase transcriptional cyclers, Rinφ, red; out-of-phase 
transcriptional cyclers, Ro/φ, orange, arrhythmically transcribed target genes, AR, black; not transcribed target genes, NE, grey; see text for details). 
B. Correlation between BMAL1 (top) and CLOCK (bottom) ChIP-Seq signal and the phase of nascent RNA expression of rhythmic 
CLOCK:BMAL1 target genes in the mouse liver (Nascent-Seq data from Menet et al., 2012). The dash lines depict the cut-offs used to partition 
the in-phase cyclers (Rinφ; from ZT02 to ZT12) to the out-of-phase cyclers (Ro/φ; from ZT12 to ZT02). Distinction is made between 
CLOCK:BMAL1 peaks targeting core clock genes (Per1, Per2, Cry2, Dbp, Rev-erbα, and Rev-erbβ; circles filled in red), extended core clock 
genes (Tef, Hlf, Gm129, and Rorγ; circles filled in orange), to those targeting clock-controlled genes (filled in blue and green for BMAL1 and 
CLOCK, respectively). CLOCK:BMAL1 peaks targeting arrhythmically transcribed genes (circles filled in black) and non expressed genes (circles 
filled in grey) are shown for comparison. C. Correlation between the phase of BMAL1 (top) or CLOCK (bottom) DNA binding and the phase of 
transcription of rhythmically transcribed CLOCK:BMAL1 target genes in the mouse liver. D. Correlation between BMAL1 ChIP-Seq signal and 







 We also examined if differences in the location of CLOCK:BMAL1 DNA binding sites 
are associated with differences in transcriptional output by mapping CLOCK:BMAL1 peaks to 
either the transcription start site (TSS), gene body or extended promoter (-10 kb to -1 kb from the 
TSS) of their target genes. While the AR and NE groups were found to be statistically different 
(chi square test; p < 0.05), we did not observe any differences between the rhythmic target groups 
(Rinφ and Ro/φ) and the arrhythmically or not expressed groups (Figure II-2 G). The vast majority 
of CLOCK:BMAL1 peaks were located within enhancers (i.e., gene body or extended promoter), 
and only ~10-19% of CLOCK:BMAL1 peaks were mapped to TSS. Finally, we examined if 
differences in the number of genes targeted by multiple CLOCK:BMAL1 peaks were associated 
with differences in transcriptional output. We found that in-phase transcriptional cyclers were 
more frequently targeted by multiple CLOCK:BMAL1 peaks, and that conversely, non-expressed 
target genes were less frequently targeted by multiple peaks (Figure II-6). However, the lack of 
differences between the Ro/φ and AR groups indicates that the presence of multiple ChIP-Seq 












Figure II-6 Contribution of CLOCK:BMAL1 Peaks Targeting the Same Genes to CLOCK:BMAL1 ChIP-Seq 
Signal and CLOCK:BMAL1 Target Gene Nascent RNA Expression.  
A. The number of CLOCK:BMAL1 target genes is displayed based on the number of CLOCK:BMAL1 ChIP-Seq peaks for each of the 4 categories 
of CLOCK:BMAL1 transcriptional output (in-phase transcriptional cyclers, Rinφ, red; out-of-phase transcriptional cyclers, Ro/φ, orange, 
arrhythmically transcribed target genes, AR, black; not transcribed target genes, NE, grey; see text for details). Top table: all CLOCK:BMAL1 
target genes; Middle table: target genes without core clock genes (Per1, Per2, Cry2, Dbp, Rev-erbα, and Rev-erbβ); Bottom table: CLOCK:BMAL1 
target genes without core clock genes (Per1, Per2, Cry2, Dbp, Rev-erbα, and Rev-erbβ) and other associated clock genes (Tef, Hlf, Gm129, and 
Rorγ). Yellow boxes indicate the location of clock genes within the table. The distribution of the number of CLOCK:BMAL1 ChIP-Seq peaks per 
gene is also displayed as a pie chart for all CLOCK:BMAL1 peaks. Groups with different letters are significantly different (Fischer's exact test 
(two-sided test); p < 0.05). B, C. BMAL1 (B) and CLOCK (C) ChIP-Seq signal at CLOCK:BMAL1 ChIP-Seq peaks (from Koike et al., 2012) is 
displayed for each of CLOCK:BMAL1 transcriptional output category. In this analysis, ChIP-Seq signal at CLOCK:BMAL1 peaks targeting the 
same gene was summed up (see panel A for the number of genes with multiple peaks for each category). Groups with different letters are 
significantly different (Kruskal-Wallis test; p < 0.05). D. Nascent RNA expression of CLOCK:BMAL1 target genes parsed based on 
CLOCK:BMAL1 target gene transcription, for all CLOCK:BMAL1 targets (left), target genes without core clock genes (middle), and target genes 
without core clock genes and other associated clock genes (Tef, Hlf, Gm129, and Rorγ). Groups with different letters are significantly different 








Taken together, our analysis indicates that CLOCK:BMAL1 heterogeneous transcriptional 
output cannot be simply attributed to differences in the phase, intensity or location of CLOCK and 
BMAL1 binding to the DNA. While stronger DNA binding intensity may contribute to rhythmic 
transcription during the light phase, additional mechanisms are likely to contribute to 
CLOCK:BMAL1 transcriptional output heterogeneity. 
 
Recruitment of PERs and CRYs at CLOCK:BMAL1 DNA binding sites does not contribute to 
the heterogeneous CLOCK:BMAL1 transcriptional output 
Circadian repression in mammals is initiated at the beginning of the night by the 
recruitment of the PER/CRY repressive complex and its associated histone deacetylases and 
methyltransferases to CLOCK:BMAL1 on DNA 78-80,82,86. Because a differential recruitment of 
PERs and CRYs at CLOCK:BMAL1 DNA binding sites could lead to differences in 
CLOCK:BMAL1-mediated transcriptional output (e.g., decreased recruitment at arrhythmically 
transcribed target genes, delayed recruitment of out-of-phase transcriptional cyclers, etc.), we 
investigated the DNA binding profile of PER1, PER2, CRY1 and CRY2 at CLOCK:BMAL1 DNA 
binding sites for each of the four transcriptional output groups using publicly available ChIP-Seq 
datasets 7. 
 Our analysis shows that PER1, PER2 and CRY2 are rhythmically recruited at 
CLOCK:BMAL1 DNA binding sites with little difference between the four transcriptional output 
groups (Figure II-7). Maximal DNA binding for PER1, PER2 and CRY2 occur at CT12-16 for all 
groups, and differences were mostly observed for CRY2, where higher ChIP-Seq signal was found 
for rhythmically expressed target genes (Figure II-7). On the other hand, analysis of CRY1 




all four groups. CRY1 is a potent circadian repressor that is preferentially recruited at the beginning 
of the light phase just prior CLOCK:BMAL1 transcription activation (i.e., CT0-4), a mechanism 
proposed to poise CLOCK:BMAL1 for transcription activation 7. We found that CRY1 recruitment 
at CT4 is significantly higher for rhythmically transcribed target genes (both Rinφ and Ro/φ) than 
for arrhythmically transcribed and non-expressed genes (Figure II-7). In addition, CRY1 
recruitment was significantly decreased in non-expressed CLOCK:BMAL1 target genes than 
arrhythmic genes at CT4. These data thus suggest that CRY1 recruitment to CLOCK:BMAL1 
DNA binding sites is, in addition to its well-characterized repressive effect, linked to rhythmic 
transcription activation. Consistent with this hypothesis are the higher levels for Ro/φ at CT12 














Figure II-7 Recruitment of PERs and CRYs to CLOCK:BMAL1 Peaks Does Not Correlate with the 
Heterogeneous CLOCK:BMAL1 Transcriptional Output. 
A. (Left) Circadian rhythm of BMAL1 and CLOCK ChIP-Seq signal in the mouse liver at CLOCK:BMAL1 DNA binding sites for each of the 4 
CLOCK:BMAL1 transcriptional output groups. (Right) Distribution of BMAL1 and CLOCK ChIP-Seq signal for each of the 4 CLOCK:BMAL1 
transcriptional output groups at the time of maximal DNA binding (CT04 for BMAL1 and CT08 for CLOCK). B. (Left) Circadian rhythm of PER1, 
PER2, CRY1, and CRY2 ChIP-Seq signal in the mouse liver at CLOCK:BMAL1 DNA binding sites for each of the 4 CLOCK:BMAL1 
transcriptional output groups. (Right) Distribution of PER1, PER2, CRY1, and CRY2 ChIP-Seq signal for each of the 4 CLOCK:BMAL1 
transcriptional output group at the time of maximal DNA binding (CT16 for PER1 and PER2, CT04 for CRY1 and CT12 for CRY2. For both A 
and B panels, datasets were retrieved from Koike et al., 2012 and re-analyzed (see Methods section for more details). Values correspond to the 
ChIP-Seq signal median for each group. To improve visualization, CT0 ChIP-Seq values were repeated at CT24. Groups with different letters are 








REV-ERBα and REV-ERBβ ChIP-Seq signal is higher at CLOCK:BMAL1 peaks targeting 
genes transcribed at night 
Based on the mechanisms mediating the delayed transcription of the CLOCK:BMAL1 
target gene Cry1 87, a model incorporating the nuclear receptors Rev-erb (repressor) and Ror 
(activator), and the D-box transcriptional factors E4bp4 (also called Nfil3; repressor), Dbp, Hlf and 
Tef (activators) has been proposed to explain the different phases of rhythmic gene expression in 
the mouse liver 87,88. In this model, co-binding of D-box transcription factors with 
CLOCK:BMAL1 is proposed to delay the phase of CLOCK:BMAL1 target genes from the 
morning to the afternoon (i.e., from ~ZT6 to ~ZT12), and additional binding of REV-ERBs and 
RORs would further delay the phase of transcription to the night (e.g., ~ZT18). To test if the 
binding of REV-ERBs and D-box transcription factors contribute to the delay of the out-of-phase 
CLOCK:BMAL1 target genes, we used publicly available ChIP-Seq datasets to determine REV-
ERBα, REV-ERBβ 89, and E4BP4 90 DNA binding intensity at CLOCK:BMAL1 enhancers. We 
found that REV-ERBα and REV-ERBβ DNA binding, which peaks at ZT10 for all target genes 89, 
is significantly higher at CLOCK:BMAL1 peaks targeting genes transcribed during the night 
consistent with the model proposed based on Cry1 expression; 87,88, and no differences were 
observed between Rinφ, AR and NE target genes (Figure II-8 A, B; Kruskal-Wallis test, p < 0.05). 
The binding of E4BP4, which is maximal at ZT22 90, was also enriched at CLOCK:BMAL1 
enhancers targeting the Ro/φ genes, but to a lesser extent than what was observed for the REV-
ERBs (Figure II-8 C). In particular, no significant difference in enrichment was observed between 
the Rinφ and the Ro/φ groups, perhaps because co-binding of both CLOCK:BMAL1 and D-box 
transcription factors drives rhythmic transcription in the afternoon around ZT12, a time used for 




analysis indicates that the binding of REV-ERBα and REV-ERBβ (and eventually E4BP4) at 
CLOCK:BMAL1 enhancers may, as suggested by others 87,88, contribute to the delayed 




Figure II-8 REV-ERBα and REV-ERBβ ChIP-Seq Signal is High at CLOCK:BMAL1 DNA Binding Sites 
Targeting Genes Transcribed at Night.  
A-C (Left). Average ChIP-Seq signal for REV-ERBα (A), REV-ERBβ (B) and E4BP4 (C) at CLOCK:BMAL1 DNA binding sites (center ± 1kb) 
for each of the 4 CLOCK:BMAL1 transcriptional output group. A-C (Right). Distribution of REV-ERBα (A), REV-ERBβ (B) and E4BP4 (C) 
ChIP-Seq signal at CLOCK:BMAL1 peaks for each of the 4 CLOCK:BMAL1 transcriptional output groups (signal for each peak was averaged at 
CLOCK:BMAL1 peak center ± 250bp). Groups are labeled as in Figure II-2. Those with different letters are significantly different (Kruskal-Wallis 
test; p < 0.05). REV-ERBα and REV-ERBβ ChIP were performed from mice liver collected at ZT10, while E4BP4 ChIP was performed from mice 








CLOCK:BMAL1 promotes rhythmic nucleosome removal independently of its transcriptional 
output 
Our inability to detect substantial differences in CLOCK:BMAL1 DNA binding that would 
explain the heterogeneity of CLOCK:BMAL1 transcriptional output suggests that mechanisms 
other than the recruitment of core clock proteins to target gene promoters control 
CLOCK:BMAL1-mediated transcription. The recent finding that CLOCK:BMAL1 promotes the 
removal of nucleosomes when bound to DNA may represent one of these mechanisms 13. Indeed, 
by mediating the removal of nucleosomes, CLOCK:BMAL1 would enable other transcription 
factors to access CLOCK:BMAL1 enhancers (most transcription factors bind better to naked DNA 
than DNA wrapped around nucleosomes).  
 To test if CLOCK:BMAL1-mediated nucleosome removal can contribute to the 
heterogeneity of CLOCK:BMAL1 transcriptional output, we examined mouse liver nucleosome 
signal over the 24-hr day at CLOCK:BMAL1 DNA binding sites for each of the transcriptional 
output groups, using a public MNase-Seq dataset (micrococcal nuclease digestion of mouse liver 
chromatin at 6-time points and high-throughput sequencing of mononucleosomes 13). Our analysis 
reveals that nucleosome signal is rhythmic at CLOCK:BMAL1 DNA binding sites for each of the 
transcriptional output categories, i.e., even at CLOCK:BMAL1 DNA binding sites targeting 













Figure II-9 CLOCK:BMAL1 Rhythmic DNA Binding is Associated with Rhythmic Nucleosome Signal, but Not 
with Rhythmic Histone Post-translational Modification and eRNA Transcription. 
A-D. Rhythmic nucleosome signal at CLOCK:BMAL1 DNA binding sites for each of the 4 CLOCK:BMAL1 transcriptional output groups: (A) 
Rhythmic-in-phase (Rinφ, red); (B) Rhythmic out-of-phase (Ro/φ, orange); (C) arrhythmic (AR, black); (D) non expressed (NE, grey) target genes). 
Nucleosome signal was retrieved from mouse liver MNase-Seq datasets 13, which consists of 6 time points each separated by 4 hours with n = 4 
mice for each time point. (Left): 6-time points rhythm of nucleosome signal at CLOCK:BMAL1 binding sites (calculated at CLOCK:BMAL1 peak 
center ± 75 bp for each peak), displayed as the average ± s.e.m. of the signal (n = 4) calculated for each mouse and for each transcriptional output 
category. The phase of rhythm (average ± s.e.m. from 4 independent rhythm) is indicated in the bottom right. Each rhythm is double-plotted for 
better visualization. (Right): average nucleosome signal for each transcriptional output group at CLOCK:BMAL1 DNA-binding sites (±0.6 kb) 
during the light phase (ZT2, ZT6, and ZT10; green) and dark phase (ZT14, ZT18, and ZT22; red/orange) of wild-type mice and in Bmal1-/- mice 
(average signal for six time points; black). E. maximal and minimal nucleosome signal from the 6-time points rhythms for each of the 
CLOCK:BMAL1 transcriptional output groups. Groups with different letters are significantly different (2-way ANOVA; p < 0.05). F. Circadian 
rhythm of H3K27ac ChIP-Seq signal in the mouse liver at CLOCK:BMAL1 DNA binding sites (calculated at CLOCK:BMAL1 peak center ± 1 
kb) for each of the 4 CLOCK:BMAL1 transcriptional output group. Datasets were retrieved from Koike et al., 2012 7 and re-analyzed (see methods 
for more details). Values correspond to the ChIP-Seq signal median for each group. Each rhythm is double-plotted for better visualization. G. 
Rhythm of enhancer RNA (eRNA) signal in the mouse liver at CLOCK:BMAL1 DNA binding sites (calculated at CLOCK:BMAL1 peak center ± 
500 bp) for each of the 4 CLOCK:BMAL1 transcriptional output groups. Datasets were retrieved from Fang et al., 2014 90 and re-analyzed (see 








Importantly, the phase of the rhythms is similar for all groups and minimal nucleosome 
signal coincides with maximal CLOCK:BMAL1 DNA binding during the light phase. Closer 
inspection of the levels of nucleosome signal and rhythm amplitude reveals important differences 
between each of the four transcriptional output categories (Figure II-9 E). First, the amplitude of 
the rhythms is significantly decreased for arrhythmically transcribed target genes. While minimal 
levels of nucleosome signal during the day are similar between the AR and Rinφ groups, 
nucleosome signal remains low during the night (i.e., when CLOCK:BMAL1 is not bound to 
DNA) at CLOCK:BMAL1 peaks targeting AR genes (Figure II-9 E). This suggests that some 
transcription factors may be still bound to DNA during the night in the AR group (when 
CLOCK:BMAL1 is not bound to DNA), thereby preventing the reformation of nucleosomes. This 
may promote transcription at night and thus lead to arrhythmic transcription. Second, the overall 
nucleosome signal is significantly lower at CLOCK:BMAL1 peaks targeting Ro/φ genes than for 
Rinφ genes, without any significant effect on the amplitude of the rhythm (Figure II-9 E). In 
addition, the time of minimal nucleosome signal is delayed by 4 hours between Rinφ and Ro/φ: 
while it coincides with the time of maximal CLOCK:BMAL1 DNA binding for Rinφ genes 
(ZT06), minimal nucleosome signal is observed at ZT10 for Ro/φ genes. This delayed nucleosome 
signal for the out-of-phase transcriptional cyclers may be explained by the significant recruitment 
of REV-ERBα and REV-ERBβ (Figure II-8 A, B). Indeed, CLOCK:BMAL1 has been recently 
proposed to facilitate circadian repression by promoting the recruitment of REV-ERBα through 
chromatin decondensation 91. Thus, the increased binding of REV-ERBs at CLOCK:BMAL1 
enhancers at ZT10 may promote a further decrease in nucleosome signal. Furthermore, anti-phase 
binding of the RORs on ROREs during the night would prevent a full nucleosome re-compaction, 




target genes. Finally, there are no significant differences of nucleosome signal between 
CLOCK:BMAL1 DNA binding sites targeting in-phase transcriptional cyclers than those targeting 
non-expressed target genes (Figure II-9 E). This intriguing result suggests that although 
CLOCK:BMAL1 is unable to promote transcription activation at NE target genes, its rhythmic 
DNA binding still mediates a rhythm in nucleosome signal. One possible explanation for this result 
is that CLOCK:BMAL1 decondenses the chromatin to facilitate the binding of other transcription 
factors, but those would not be recruited at NE target genes except under specific conditions (e.g. 


















Figure II-10 Rhythmic Nucleosome Signal at CLOCK:BMAL1 DNA Binding Sites.  
A-D: Nucleosome signal was retrieved from mouse liver MNase-Seq datasets (Menet et al., 2014), which consists of 6 time points each separated 
by 4 hours with n = 4 mice for each time point. Each graph displays a 6-time points rhythm of nucleosome signal at CLOCK:BMAL1 binding sites 
(calculated at CLOCK:BMAL1 peak center ± 75 bp for each peak), displayed as the average ± s.e.m. of the signal (n = 4) calculated for each mouse 
and for each transcriptional output category: (A) Rhythmic-in-phase (Rinφ, red); (B) Rhythmic out-of-phase (Ro/φ, orange); (C) arrhythmic (AR, 
black); (D) non expressed (NE, grey) target genes). The phase of rhythm (average ± s.e.m. from 4 independent rhythm, calculated by Fourier 
transform) is indicated in the bottom right. Each rhythm is double-plotted for better visualization. For both Rinφ and Ro/φ groups, the nucleosome 
rhythm is calculated at all CLOCK:BMAL1 peaks targeting rhythmic target genes (left), or only at peaks targeting rhythmic non core clock genes 
(removal of nucleosome signal at peaks targeting Cry2, Dbp, Rev-erbα, and Rev-erbβ for the Rinφ group, and of the peaks targeting Per1 and Per2 
for the Ro/φ group. E: maximal and minimal nucleosome signal from the 6-time points rhythms for each of the CLOCK:BMAL1 transcriptional 






CLOCK:BMAL1 does not directly contribute to the transcriptional activity of its enhancers  
Our data indicate that CLOCK:BMAL1 rhythmic DNA binding promotes the rhythmic 
removal of nucleosomes at all four transcriptional output categories. We then asked if 
CLOCK:BMAL1 can also promote the formation of transcriptionally active enhancers. To address 
this question, we used public datasets 7,19,90 to examine the rhythmic pattern of two independent 
markers of enhancer activity at CLOCK:BMAL1 DNA binding sites: the post-translational 
modification H3K27 acetylation (H3K27ac), which positively correlates with enhancer activity at 
almost all enhancers and TSS 92, and the expression levels of enhancer RNA (eRNA), which are 
relatively short non-coding RNA molecules (50-2000 nucleotides) transcribed at active enhancer 
regions 93. 
 While mouse liver H3K27ac ChIP-Seq signal is rhythmic and high during the light phase 
at CLOCK:BMAL1 DNA binding sites targeting in-phase transcriptional cyclers (consistent with 
CLOCK:BMAL1 directly facilitating the acetylation of H3K27; Figure II-9 F and Figure II-11), 
significant differences were observed at CLOCK:BMAL1 DNA binding sites targeting the other 
3 transcriptional output categories. Rhythmic H3K27ac rhythm is delayed for the out-of-phase 
transcriptional cyclers, and the amplitude of H3K27ac rhythm is significantly dampened at 
CLOCK:BMAL1 DNA binding sites targeting arrhythmically transcribed genes (Figure II-9 F and 
Figure II-11 A). Remarkably, levels of H3K27ac are close to background levels at 
CLOCK:BMAL1 peaks targeting non-expressed genes. Given that CLOCK:BMAL1 rhythmically 
binds to relatively similar levels for all four transcriptional output categories, our analysis suggests 
that CLOCK:BMAL1 DNA binding does not directly contribute to the acetylation of H3K27.  
 To extend on this observation, we then examined another marker of enhancer 




using a publicly available GRO-Seq dataset 90. The analysis confirmed the results obtained with 
H3K27ac (Figure II-9 G). Rhythmic eRNA expression is only observed at CLOCK:BMAL1 
enhancers targeting rhythmically transcribed genes, and eRNA expression at enhancers targeting 
non-expressed genes is dramatically decreased to levels close to background (Figure II-9 G). 
Importantly, these differences in eRNA expression between the four CLOCK:BMAL1 
transcriptional output categories are further corroborated by similar variations in RNA Polymerase 
II (Pol II) ChIP-Seq signal at CLOCK:BMAL1 enhancers (Figure II-11 C). Altogether, our 
analysis therefore demonstrates that, contrary to what has been typically found for core clock 
genes, CLOCK:BMAL1 DNA binding is not sufficient to promote the activation of its enhancers. 
Instead, our results suggest that CLOCK:BMAL1 rhythmically opens the chromatin to facilitate 
the binding of other transcription factors at its enhancers, and that the nature of these transcription 



















Figure II-11 CLOCK:BMAL1 Does Not Directly Promote H3K27ac Post-Translational Modification.  
A. Circadian rhythm of H3K27ac ChIP-Seq signal in the mouse liver at CLOCK:BMAL1 DNA binding sites (Left; blue background) or at non-
CLOCK:BMAL1 enhancers located in CLOCK:BMAL1 target genes (Right; green background) for each of the 4 CLOCK:BMAL1 transcriptional 
output groups: rhythmic-in-phase (Rinφ, red); rhythmic out-of-phase (Ro/φ, orange); arrhythmic (AR, black); and non expressed (NE, grey) target 
genes. Datasets were retrieved from Koike et al., 2012 (top) or Vollmers et al., 2012 (bottom) and re-analyzed (see methods section for more 
details). Values correspond to the ChIP-Seq signal median for each group, and were calculated for each CLOCK:BMAL1 peak as the average of 
reads/bp at CLOCK:BMAL1 DNA binding sites center ± 1 kb normalized to one million sequencing reads. For each dataset, H3K27ac ChIP-Seq 
signal was further normalized by mean normalization to account for the differences in ChIP-Seq efficiency between each sequencing sample (bottom 
graphs for each datasets). This normalization assumes that the overall genome-wide levels of H3K27ac are constant at any time in the mouse liver. 
To this end, we normalized H3K27ac ChIP-Seq signal for each peak to the averaged H3K27ac signal calculated at the top 40,000 DNase 
hypersensitive sites for each time point  Graphs are double-plotted to improve visualization. B. Rhythm of enhancer RNA (eRNA) signal in the 
mouse liver at enhancers targeting a CLOCK:BMAL1 target gene and that do not harbor a CLOCK:BMAL1 DNA binding site (calculated at 
CLOCK:BMAL1 peak center ± 500 bp) for each of the 4 CLOCK:BMAL1 transcriptional output group. Datasets were retrieved from Fang et al., 
2014 90 and re-analyzed (see methods section for details). Values correspond to the eRNA signal median for each group. Each rhythm is double-
plotted for better visualization. C. Rhythm of RNA Polymerase II ChIP-Seq signal in the mouse liver at CLOCK:BMAL1 enhancers (top) and 
enhancers targeting a CLOCK:BMAL1 target gene but without a CLOCK:BMAL1 DNA binding site for each of the 4 CLOCK:BMAL1 
transcriptional output group. Datasets were retrieved from Le Martelot et al., 2012 77, re-analyzed and normalized by a ranking analysis (see methods 






Differential recruitment of transcription factors at CLOCK:BMAL1 enhancers 
To test our hypothesis that transcription factors bind at CLOCK:BMAL1 enhancers to 
contribute to their transcriptional activity and thereby impact on CLOCK:BMAL1-mediated 
transcription, we assessed if transcription factors were differentially recruited at 
CLOCK:BMAL1 DNA binding sites within each transcriptional output group. To this end, we 
performed a DNA binding motif analysis using HOMER Software Suite that we further validated 
using mouse liver transcription factor ChIP-Seq datasets. As expected, the motif analysis 
revealed that CLOCK:BMAL1 DNA binding motif (e-box of the sequence CACGTG) is highly 
enriched at CLOCK:BMAL1 enhancers for all transcriptional output categories (Figure II-12 A). 
Surprisingly however, we found that motifs for liver-specific transcription factors (e.g., Cebp, 
Hnf1, Hnf4 and Hnf6) were also enriched for all four transcriptional output categories, and thus 
even at CLOCK:BMAL1 enhancers targeting non-expressed genes (Figure II-12 B,  
Figure II-13). On the contrary, motifs for ubiquitous transcription factors (u-TFs; broadly 
expressed transcription factors with a transcriptional activity regulated by external factors) were 
almost always enriched for specific CLOCK:BMAL1 transcriptional output groups (Figure II-12 
C,  
Figure II-13). For example, CRE motif was enriched at all CLOCK:BMAL1 enhancers except 
those targeting out-of-phase transcriptional cyclers, and FXR motif was enriched at all 
CLOCK:BMAL1 enhancers except those targeting out-of-phase transcriptional cyclers. 
Noticeably, the motifs for NF-κB which binds to DNA and becomes transcriptionally active 
upon infection and inflammation; 94,95, and CTCF which establishes discrete functional 





Figure II-12 Tissue-Specific and Ubiquitous Transcription Factors Are Differentially Recruited at 
CLOCK:BMAL1 Enhancers.  
A-C. Enrichment for the DNA binding motif of CLOCK:BMAL1 (A), tissue-specific transcription factors (B) and ubiquitous transcription factors 
(C) at CLOCK:BMAL1 DNA binding sites for each of the four CLOCK:BMAL1 transcriptional output categories. Enrichment was calculated 
using HOMER and is reported as the ratio between the calculated enrichment over the calculated background. * q < 0.05 (Benjamini-Hochberg 
procedure). D-F. ChIP-Seq signal of tissue-specific transcription factors (D), ubiquitous transcription factors (E), and transcriptional co-activators 
/ RNA Polymerase II at ZT6 (F) at CLOCK:BMAL1 DNA binding sites (peak center ± 250bp) for each of the transcriptional output categories. 
Groups with different letters are significantly different (Kruskal-Wallis test; p < 0.05). G. Transcription factor DNA binding variability index at 
CLOCK:BMAL1 DNA binding sites. The TF DNA binding variability index reflects differential TF DNA binding by calculating the variance of 
TF ChIP-Seq signal between the four CLOCK:BMAL1 transcriptional output groups (see Methods for details). The variability index is displayed 
as a dot for each TF: CLOCK, BMAL1, PER1, PER2, CRY1, CRY2 (blue), seven ts-TFs (CEBPA, CEBPB, FOXA1, FOXA2, HNF1, HNF4A, 
and HNF6; red), thirteen u-TFs (REV-ERBα, REV-ERVβ, RORα, E4BP4, RXR, LXR, PPARα, GR-ZT12, E2F4, STAT5, BCL6, ERα, and 
GABPA; green), as well as for p300, CBP, and Pol II at seven time points (ZT02 to ZT26) (black). The horizontal lines represent the variability 
index median for the first 3 groups of TF. ChIP-Seq datasets used in this analysis are described in the method section. The variability index was 
calculated using all CLOCK:BMAL1 peaks analyzed in Fig. 1 (left), or CLOCK:BMAL1 peaks that do not target a clock gene (removal of TF 







Figure II-13 Transcription Factor DNA Binding Motif Analysis at CLOCK:BMAL1 Enhancers and Based on 
CLOCK:BMAL1 Transcriptional Output. 
Enrichment for transcription factor DNA binding motifs (calculated using the HOMER software suite) at CLOCK:BMAL1 DNA binding sites for 
each of the four CLOCK:BMAL1 transcriptional output categories: rhythmic-in-phase (Rinφ, red); rhythmic out-of-phase (Ro/φ, orange); 
arrhythmic (AR, black); and non expressed (NE, grey) target genes. Enrichment is reported as the ratio between the calculated enrichment over the 
calculated background. * q < 0.05 (Benjamini-Hochberg procedure). Motif enrichment is shown for: CLOCK:BMAL1 (A); tissue-specific 







To assess the relevance of this difference of motif enrichments between tissue-specific (ts-
TFs) and u-TFs, we determined the DNA binding pattern of several transcription factors at 
CLOCK:BMAL1 enhancers in the mouse liver using publicly available transcription factors ChIP-
Seq datasets 99-104. This in vivo analysis largely confirmed the computational motif analysis: most 
liver-specific TFs were found to bind at CLOCK:BMAL1 DNA binding sites independently of the 
transcriptional output, whereas u-TFs were more specifically enriched in specific 
CLOCK:BMAL1 transcriptional output groups (Figure II-12 D, E, Figure II-14). For example, 
Hnf4a and Hnf1 are the only liver-specific TF to exhibit a differential binding between 
CLOCK:BMAL1 transcriptional output groups of the six TFs tested (Foxa1, Foxa2, Hnf1, Hnf4A, 
Hnf6 and Cepba). Conversely, all twelve u-TFs investigated exhibit DNA binding differences at 
CLOCK:BMAL1 enhancers between categories of transcriptional output (Figure II-12 D, E, 
Figure II-14). Although each u-TF bound to different subsets of CLOCK:BMAL1 enhancers, u-
TF recruitment was generally higher in rhythmically expressed target genes and lower in non-
expressed target genes compared to the arrhythmic CLOCK:BMAL1 target group. (Figure II-12 




To further characterize the differences in TF DNA binding between CLOCK:BMAL1, u-TFs and 
ts-TFs, we computed a TF DNA binding variability index by calculating the standard deviation of 
the ChIP-Seq signal between the 4 CLOCK:BMAL1 transcriptional output groups (see Methods 
for details). We found that the DNA binding variability at CLOCK:BMAL1 peaks is comparable 
between CLOCK:BMAL1 and ts-TFs, whereas there is significantly more variability for u-TFs 
than for CLOCK and BMAL1 when peaks targeting core clock genes are removed from the 
analysis (Figure II-12 G). While there are variability index differences among ts-TFs and u-TFs, 
this analysis further supports our finding that u-TF recruitment at CLOCK:BMAL1 peaks is 


















Figure II-14 Transcription Factor ChIP-Seq Signal at CLOCK:BMAL1 Enhancers and Based on 
CLOCK:BMAL1 Transcriptional Output. 
Mouse liver ChIP-Seq signal of tissue-specific transcription factors (A), ubiquitous transcription factors (B, C), and transcriptional co-activators / 
RNA Polymerase II at ZT10 (D) at CLOCK:BMAL1 DNA binding sites (peak center ± 250bp) for each of the transcriptional output categories. 
ChIP-Seq signal is represented for each output group based on its distribution (every decile). Groups with different letters are significantly different 








CLOCK:BMAL1 likely cooperates with other transcription factors to regulate the transcription 
of its direct target genes  
Altogether, our data indicate that the mechanisms by which CLOCK:BMAL1 regulates 
transcription of clock-controlled genes differ from the well-characterized CLOCK:BMAL1-
mediated regulation of core clock gene expression. Specifically, our data show that although 
CLOCK:BMAL1 mediates rhythmic nucleosome removal at its enhancers, it is not sufficient to 
generate an active enhancer or drive rhythmic transcription. We thus propose a model whereby 
CLOCK:BMAL1 regulates transcription of clock-controlled genes by rhythmically opening 
chromatin to facilitate the binding of other transcription factors at its enhancers (Figure II-16 A). 
This possibility is supported by results showing that nucleosome signal is rhythmic at the DNA 
binding sites of several TFs when those sites are located close to a CLOCK:BMAL1 peak, and not 




Figure II-15 Analysis of Nucleosome Signal Over the 24-hr Day at the DNA Binding Sites of Two Tissue-
specific TF and Two Ubiquitous TF in the Mouse Liver. 
Nucleosome signal at four TF DNA binding sites was retrieved from mouse liver MNase-Seq datasets (Menet et al., 2014), which consists of 6 
time points each separated by 4 hours with n = 4 mice for each time point. MNase-Seq data are displayed for two tissue-specific TFs: FOXA2 (A) 
and HNF6 (B), and two ubiquitous TFs: REV-ERBα (C) and ERα (D). Nucleosome signal was calculated at TF peak center ± 75 bp for each peak 
and at each TF ChIP-Seq peak coordinate, and is displayed as the average ± s.e.m of the signal (n = 4) calculated for each mouse. Each rhythm is 
double-plotted for better visualization. (Left, A-D) Nucleosome signal at TF ChIP-Seq peaks harboring a CLOCK:BMAL1 peak (blue), or at the 
top 10,000 TF ChIP-Seq peaks that do not harbor a CLOCK:BMAL1 peak (green). (Right, A’-D’) Nucleosome signal at TF ChIP-Seq peaks 
harboring a CLOCK:BMAL1 peak, and parsed based on CLOCK:BMAL1 transcriptional output: Rhythmic-in-phase (Rinφ, red), Rhythmic out-








Consequently, the transcriptional activities of these transcription factors would dictate the 
transcriptional outcome of clock-controlled genes rather than CLOCK:BMAL1 (Figure II-16 A). 
For example, binding of positive transcription factors along with CLOCK:BMAL1 would activate 
enhancers and lead to transcription activation during the day, whereas binding of transcriptional 
repressors (e.g., REV-ERBα/β) would inhibit CLOCK:BMAL1 enhancer activity and thereby 
contribute to rhythmic transcription peaking during the night, in anti-phase with CLOCK:BMAL1 
DNA binding (Figure II-16 A). If no transcription factors are recruited (e.g., inducible transcription 
factors), CLOCK:BMAL1 enhancers remain silent and target genes are not expressed or are 
arrhythmically expressed (Figure II-16 A). Arrhythmically expressed genes at CLOCK:BMAL1 
enhancers may also have positive transcription factors bound at all times overriding the absence 
of CLOCK:BMAL1 DNA binding at night (see result section about rhythmic nucleosome signal 
and Figure II-9 E). Our results also suggest that u-TFs regulate CLOCK:BMAL1 transcriptional 
output more prevalently than ts-TFs. It may be that ts-TFs facilitate the binding of 
CLOCK:BMAL1 at tissue-specific enhancers rather than contributing to CLOCK:BMAL1 
transcriptional output (see discussion). To validate this model experimentally, we investigated how 
i) Bmal1 knockout, and ii) changes in environmental conditions (that alter u-TFs transcriptional 
activities) affect CLOCK:BMAL1 transcriptional output.  
If the activity of u-TFs contributes to CLOCK:BMAL1 regulation of clock-controlled gene 
transcription, then, a knockout of Bmal1 (which eliminates CLOCK:BMAL1-mediated 
transcription 105) should differentially affect the expression of CLOCK:BMAL1 target genes. 
Specifically, target gene expression levels in Bmal1-/- mouse should be arrhythmic and low for 
the in-phase transcriptional cyclers (no recruitment of positive transcription factors at 




transcription cyclers (no recruitment of repressors at CLOCK:BMAL1 enhancers). These effects 
should also be more obvious during the light phase when CLOCK:BMAL1 binds to DNA. In 
addition, Bmal1 knockout should have a reduced effect on arrhythmically and non-expressed target 
genes. These predictions were confirmed by analyzing a public dataset that characterized the 
genome-wide effect of Bmal1 knockout in the mouse liver using RNA-Seq of rRNA-depleted total 
RNA (Figure II-16 B, C) 106. For both intronic and exonic RNA-Seq signal, the expression of Rinφ 
genes in Bmal1-/- mouse liver is at the trough level of wild-type mice, and at peak levels in Ro/φ 
genes. Moreover, Bmal1 knockout does not significantly affect the expression levels of arrhythmic 
























Figure II-16 CLOCK:BMAL1 Regulation of Clock-controlled Gene Expression Likely Relies on the 
Cooperation of CLOCK:BMAL1 with Other Transcription Factors. 
A. Proposed model incorporating tissue-specific (ts-TFs) and ubiquitous (u-TFs) transcription factors into CLOCK:BMAL1 regulation of clock-
controlled gene transcription. See text for details. B, C. Intron (B) and exon (C) signals of direct CLOCK:BMAL1 target genes classified based on 
their transcriptional output (Rinφ: in-phase transcriptional cyclers; Ro/φ: out-of-phase transcriptional cyclers; AR: arrhythmically transcribed target 
genes; NE: non-expressed target genes), in wild-type (left) and Bmal1-/- (right) mouse liver. Values correspond to the median RPKM for each 
transcriptional output group, and are displayed as the average ± s.e.m. of four (wild-type) or two (Bmal1-/-) independent samples for each time 
point. Data were retrieved from public RNA-Seq datasets 106, and are double-plotted for better visualization. D-G. Rhythm of mRNA expression in 
the liver of mice fed ad libitum (blue) or fasted for at least 22 hours (orange). Data were retrieved from a public dataset 107. Mouse liver mRNA 
expression is displayed for Clock and Bmal1 (D), as well as CLOCK:BMAL1 target genes that are rhythmically expressed (E), arrhythmically 






 Our model also predicts that the transcriptional output of CLOCK:BMAL1 target genes 
can be altered by environmental changes that affect u-TF DNA binding capacity. External signals 
that activate or repress the binding of u-TFs are predicted to impact CLOCK:BMAL1 cooperation 
with other transcription factors, and thereby change the transcriptional output of CLOCK:BMAL1 
target genes. For example, signals that enable the recruitment of positive transcription factors at 
CLOCK:BMAL1 enhancers could increase the amplitude of rhythmic transcription and/or initiate 
the rhythmic expression of target genes that are arrhythmic under control conditions. Conversely, 
signals that inhibit the binding of transcription factors that normally cooperate with 
CLOCK:BMAL1 could blunt the rhythmic expression of some CLOCK:BMAL1 target genes. To 
test this hypothesis, we analyzed how fasting, which is known to affect the transcriptional activity 
of many u-TFs 108,109, alters CLOCK:BMAL1 target gene expression in the mouse liver using a 
public dataset 107. Strikingly, while the expression of Clock, Bmal1 and several direct rhythmic 
target genes (e.g., Phf17, Slc16a2) are unaffected by fasting, some other targets exhibit a 
significantly altered gene expression profile (Figure II-16 D-G, Figure II-17 for additional 
examples). For example, some rhythmic target genes become arrhythmically expressed under 
fasting (e.g., Sgk2, Flcn) while other targets exhibit an increased amplitude of expression (e.g., 




Figure II-17 Additional Examples of CLOCK:BMAL1 Target Genes Exhibiting Changes in Expression 
Under Fasting Condition in the Mouse Liver. 
Rhythm of mRNA expression in the liver of mice fed ad libitum (blue) or fasted for at least 22 hours (orange). Data were retrieved from a public 
dataset (Vollmers et al., 2009). Mouse liver mRNA expression is displayed for CLOCK:BMAL1 target genes that are rhythmically expressed in 
the liver of mice fed ad libitum, and that exhibit under fasting condition a decrease in the rhythm amplitude (first column), no change (second 
column) or an increase in the rhythm amplitude (third column). Mouse liver mRNA expression is also displayed for CLOCK:BMAL1 target genes 







Remarkably, some direct CLOCK:BMAL1 target genes that are arrhythmically or not 
expressed under ad libitum condition become rhythmically expressed under fasting condition 
(Figure II-16 F, G). Because not all CLOCK:BMAL1 target genes are equally affected by fasting, 
these results cannot simply be explained by a global change in CLOCK:BMAL1 transcriptional 
activity under fasting condition. One possibility is that fasting enhances or represses the 
transcriptional capabilities of several u-TFs that cooperate with CLOCK:BMAL1, thereby altering 
the transcriptional output of many direct CLOCK:BMAL1 target genes. Similar results were found 
by analyzing a public dataset investigating the effect of high-fat diet on rhythmic gene expression 




Figure II-18 Effect of High-fat Diet on CLOCK:BMAL1 Target Gene Expression.  
A-D. Six-time point rhythm of liver mRNA expression in mice fed with normal chow (black) or high fat diet (blue). Values were retrieved from a 
public dataset 110 and correspond to the average ± s.e.m. of 3 independent samples. Mouse liver mRNA expression is displayed for Clock and Bmal1 
(A), and some CLOCK:BMAL1 target genes that are rhythmic under both normal chow and high fat diet (B); normal chow only (C); and high fat 






Based on the mechanisms by which CLOCK:BMAL1 regulates the expression of several 
core clock genes, it is commonly assumed that the rhythmic binding of CLOCK:BMAL1 to DNA 
is necessary and sufficient to drive the rhythmic transcription of its target genes. However, the 
recent characterization of CLOCK and BMAL1 cistromes in the mouse liver revealed that 
CLOCK:BMAL1 target gene transcription is highly heterogeneous, thereby suggesting that 
CLOCK:BMAL1 regulation of clock-controlled gene expression relies on more complex 
mechanisms than those underlying core clock gene rhythmic transcription 7,12,83,84. We report here 
that CLOCK:BMAL1 heterogeneous transcriptional output does not stem from differences in the 
DNA binding profiles of CLOCK and BMAL1, or the PER/CRY circadian repressive complex. 
Instead, we found that while CLOCK:BMAL1 rhythmically promotes chromatin decondensation 
at its enhancers, it is not sufficient to promote transcription activation. Based on these data and the 
characterization of transcription factor DNA binding profiles at CLOCK:BMAL1 enhancers, we 
propose that CLOCK:BMAL1 regulates the expression of clock-controlled genes by generating a 
permissive chromatin landscape that facilitates the binding of other transcription factors at its 
enhancers rather than directly promoting rhythmic transcription. Interestingly, analysis of a 
random set of genes not directly targeted by CLOCK:BMAL1 but exhibiting similar profiles of 
expression of the four CLOCK:BMAL1 transcriptional output categories suggests that this 




Figure II-19 Analysis of Nucleosome Signal, Enhancer Activity, and TF DNA Binding at Cis-regulatory Regions 
Targeting Non-CLOCK:BMAL1 Target Genes.  
Analysis of a random set of genes not targeted by CLOCK:BMAL1 and transcribed similarly to the 4 CLOCK:BMAL1 transcriptional output 
groups (n = 125 genes for each group) was performed to determine the extent to which the findings reported in the manuscript are specific to 
CLOCK:BMAL1. The same criteria as those used for the characterization of CLOCK:BMAL1 transcriptional output were used, and groups are 
thus similarly referred as Rhythmic-in-phase (Rinφ, dark blue), Rhythmic out-of-phase (Ro/φ, light blue), arrhythmic (AR, black), and non 
expressed (NE, grey). Cis-regulatory regions targeting the randomly selected control genes are defined as DNase I hypersensitive sites (DHS) 
located within -10kb of the TSS to +1kb of the TTS (similarly to what was done for CLOCK:BMAL1 target genes). Analysis of these DHS suggests 
that many of our findings are specific to CLOCK:BMAL1 A. Heatmap displaying nascent RNA expression of the random set of genes and parsed 
based on the transcriptional output. Nascent-Seq signal was ordered based on the phase of nascent RNA oscillations for the in-phase and out-of-
phase transcriptional cyclers. Ordering of arrhythmically transcribed genes is based on the peak time of maximal expression; the lack of a distinctive 
24-hr rhythm profile of nascent RNA expression over the 48-hr time-scale is indicative of arrhythmic transcription. NE genes are not displayed due 
to the lack of expression. B. Average nascent RNA expression level for the 4 control groups. C-D. BMAL1 (C) and CLOCK (D) ChIP-Seq signal 
at DNase I hypersensitive sites (DHS) targeting the randomly selected control genes. ChIP-Seq signal for CLOCK:BMAL1 target genes is provided 
for comparison. E. Nucleosome rhythm at DHS targeting the randomly selected control genes (similar to Figure II-9 A-D). F-H. H3K27ac, Pol II 
and eRNA expression at DHS targeting the randomly selected control genes (similar to Figure II-9 F, Figure II-11 C and Figure II-4 G, respectively). 
I-K. ts-TF (I), u-TF (J), and p300 and Pol II (K) ChIP-Seq signal at DHS targeting the randomly selected control genes (similar to Figure II-12 D-






 The current models describing the regulation of rhythmic gene expression by circadian 
clocks in other eukaryotes are also based on how core clock components regulate their own 
transcription via transcriptional feedback loops. For example, the mechanisms underlying 
transcriptional regulation by CLOCK:BMAL1 orthologs in Neurospora (WCC for White Collar 
Complex) and Drosophila (CLK:CYC heterodimer) are based largely on how they regulate the 
expression of the core clock genes frequency (in Neurospora), and period and timeless (in 
Drosophila) 61,111-113. Given that the circadian clock mechanisms are highly conserved in 
eukaryotes, it is likely that both WCC and CLK:CYC also regulate their target gene expression by 
remodeling the chromatin and facilitating the binding of other transcription factors. Consistent 
with this hypothesis, WCC and CLK:CYC transcriptional outputs are also heterogeneous 114,115, 
and both recruit chromatin remodelers to promote nucleosome eviction at their binding sites 116-
120.  
 The recent characterization of many transcription factor cistromes revealed that the number 
of transcription factor DNA binding sites often exceeds the number of anticipated target genes, 
suggesting that many of these DNA binding sites are non-functional 121,122. Although many 
CLOCK:BMAL1 DNA binding sites could be considered as non-functional because they target 
arrhythmically or not expressed genes, the observation that CLOCK:BMAL1 rhythmically 
promotes nucleosome eviction at enhancers targeting both arrhythmically expressed (albeit with a 
decreased amplitude) and non-expressed genes instead indicates that CLOCK:BMAL1 rhythmic 
DNA binding is not “silent”. More specifically, our data suggest that the majority of 
CLOCK:BMAL1 DNA binding events are functional, in that they rhythmically shape the 
chromatin landscape, and that transcription activation requires additional downstream events to be 




our finding that CLOCK:BMAL1 does not directly generate a transcriptionally active enhancer. 
Indeed, both H3K27ac ChIP-Seq signal and eRNA transcription are minimal at CLOCK:BMAL1 
enhancers targeting non-expressed genes, and are delayed at CLOCK:BMAL1 enhancers targeting 
out-of-phase transcriptional cyclers (Figure II-9F, G). The observation that H3K27ac ChIP-Seq 
signal at CLOCK:BMAL1 enhancers correlates with CLOCK:BMAL1 transcription output rather 
than CLOCK:BMAL1 DNA binding phase/intensity seems inconsistent with the well-described 
interactions between core clock proteins and histone modifiers 7,70-75,81, and thus raises the question 
on whether or not CLOCK:BMAL1 DNA binding occurs with enzymatically activate histone 
modifiers. Interestingly, instances of enhancers bound by p300/CBP but lacking H3K27ac (and 
transcriptional activity) have been described at enhancers targeting developmental genes in human 
ES cells 123,124. Those enhancers, which are termed poised enhancers, share most of the properties 
of active enhancers, including similar levels of nucleosome depletion, p300, and chromatin 
remodelers binding. However, these poised enhancers are unable to drive gene expression in ES 
cells until they acquire H3K27ac signal during differentiation 124. Here we found that the binding 
of CBP and p300 at non-expressed target genes is above background levels, and that the differences 
in CBP and p300 DNA binding between non-expressed and expressed target genes are smaller 
than those observed for H3K27ac and Pol II ChIP-Seq signal (Figure II-9 F, Figure II-12 F, Figure 
II-14). It is thus tempting to speculate that the concept of poised enhancers extends to the circadian 
field, with CLOCK:BMAL1 rhythmically priming the chromatin landscape of “circadian poised 
enhancers”. While those circadian poised enhancers would share properties of active enhancers 
(similar CLOCK:BMAL1 DNA binding, nucleosome eviction rhythm, etc.), they would be 
transcriptionally inactive and require the binding of other transcription-associated factors needed 




 Investigation of the transcription factors that are recruited at CLOCK:BMAL1 enhancers 
revealed a surprising difference between u-TFs and ts-TFs. In particular, ts-TFs are recruited at 
similar levels between expressed and non-expressed CLOCK:BMAL1 target genes, suggesting 
that they do not significantly contribute to the heterogeneity of CLOCK:BMAL1 transcriptional 
output. Because ts-TFs are known to establish tissue-specific enhancers and enable the binding of 
u-TFs in a tissue-specific manner 125-128, it is likely that ts-TFs contribute primarily to the binding 
of CLOCK:BMAL1 at tissue-specific enhancers and thus enable the generation of a tissue-specific 
circadian transcriptional program 56,57,66,129. Contrary to ts-TFs, u-TFs appear to bind at 
CLOCK:BMAL1 enhancers targeting specific transcriptional output categories, suggesting that 
their nature (i.e., activator or repressor, constitutively active or inducible), as well as mode of 
cooperation with CLOCK:BMAL1, likely contributes to the heterogeneity of CLOCK:BMAL1 
target gene transcription. For example, the transcriptional repressors REV-ERBα and REV-ERBβ 
are enriched at CLOCK:BMAL1 enhancers targeting out-of-phase transcriptional cyclers, 
agreeing with the recently proposed model of facilitated repression whereby CLOCK:BMAL1 
remodels its enhancer chromatin to facilitate the recruitment of REV-ERBs and delay the 
transcriptional output of some of its target genes 91. Since rhythmically expressed genes tend to 
exhibit higher u-TF ChIP-Seq signal than arrhythmic and non-expressed genes (Figure II-14), and 
given the low expression of in-phase transcriptional cyclers in Bmal1-/- mice, we propose that a 
major function of CLOCK:BMAL1 is to facilitate the recruitment of both positive and negative 
transcription factors to drive the rhythmic transcription of clock-controlled genes (i.e., not just to 
facilitate the binding of the circadian repressors REV-ERBα/β). Although the mechanisms 
underlying of this cooperation between CLOCK:BMAL1 and other transcription factors are still 




130-135, and several papers have shown that two non-interacting TFs can synergistically bind to 
DNA through a mechanism whereby the first TF leads to partial unwrapping of nucleosomal DNA, 
thus making the site of the second TF more accessible and thereby increasing DNA binding. 
 This cooperation between CLOCK:BMAL1 and other TFs may explain why a large 
fraction of CLOCK:BMAL1 target genes are not expressed: u-TF recruitment is not sufficient to 
activate CLOCK:BMAL1 enhancers and promote transcription. In support of this idea, 
CLOCK:BMAL1 enhancers targeting non-expressed target genes are enriched for the NF-κB 
transcription factor motif, which is known to mediate transcriptional response to immune and 
inflammatory responses 94. Because the genome-wide characterization of circadian clock 
mechanisms has mostly been carried out in healthy mice raised in standard laboratory conditions, 
NF-κB is likely inactive, sequestered in the cytosol and its target genes are not expressed. 
CLOCK:BMAL1 may thus prime NF-κB DNA binding upon inflammation or immune response, 
thereby triggering a rhythmic response to acute infection. Interestingly, such a mechanism may 
explain, at least in part, why the immune host response oscillates based on the time-of-day bacterial 











We also found that CLOCK:BMAL1 enhancers at non-expressed target genes are enriched for the 
transcription factor CTCF (CCCTC-binding factor; Figure II-12 A). CTCF is known to promote 
long-range interactions between two or more genomic sequences, and thus bring sequences that 
are far apart in the linear genome into close proximity 97. This may suggest that some 
CLOCK:BMAL1 DNA binding sites situated in non-expressed gene loci actually target other 
clock-controlled genes located hundreds of kilobases apart through long-range interactions, as 
recently described for one CLOCK:BMAL1 DNA binding site in the mouse liver 140. Although it 
is impossible to assess the prevalence of CLOCK:BMAL1 binding sites mediating long-range 
chromatin interactions without the appropriate experiments, we found a few examples suggesting 




Figure II-20 The Enrichment of CTCF (CCCTC-binding Factor) at CLOCK:BMAL1 Enhancers Targeting 
Non-expressed Genes May Underscore the Role of Long-range Chromatin Interactions between 
CLOCK:BMAL1 Enhancers and its Target Genes.  
Visualization file of ChIP-Seq signal at two CLOCK:BMAL1 enhancers (yellow boxes) targeting non expressed genes (Top: Lif and Bottom: Adc), 
and exhibiting significant CTCF ChIP-Seq signal. Arrows with question marks indicate a potential CTCF-mediated long-range chromatin 







Transcription regulation in higher eukaryotes relies on the activity of multiple enhancers 
141,142. It is thus likely that CLOCK:BMAL1 target gene expression results from a complex 
integration between CLOCK:BMAL1 enhancers and other enhancers. Our results indicate that 
enhancers targeting the same gene typically share the same transcriptional activity profiles 
(H3K27ac signal, eRNA levels, and Pol II ChIP-Seq signal; Figure II-11). Based on these 
observations, we cannot exclude that other enhancers targeting arrhythmically expressed 
CLOCK:BMAL1 target genes outcompete CLOCK:BMAL1 enhancers, to produce constitutive 
expression. Further experiments aimed at revealing hierarchical influences of enhancers on the 
regulation of gene expression at the genome-wide level will be required to directly test this 
hypothesis.  
 It was recently proposed that altering the environmental conditions can reprogram 
circadian transcriptional programs (e.g., high-fat diet and antibiotics treatment in the liver, LPS 
treatment in the lung 110,143-145). Our model that CLOCK:BMAL1 regulates the expression of clock 
controlled genes by facilitating the binding of other TFs represents a mechanistic framework for 
explaining how environmental signals can mediate this transcriptional reprogramming. Indeed, 
activation of new signaling pathways by environmental changes is likely to modulate multiple 
transcriptional programs, thereby altering how CLOCK:BMAL1 cooperate with those programs 
to drive rhythmic gene expression. Importantly, this mechanism may also explain, at least in part, 
why the number and nature of rhythmically expressed genes vary between datasets and laboratories 
146-148. Indeed, differences in diet, light environment and housing may all lead to changes in u-TF 
transcriptional activity, which may in turn affect clock-controlled gene expression.  
 In conclusion, our data indicate that the mechanisms by which CLOCK:BMAL1 regulates 




primary function of CLOCK:BMAL1 is to regulate the chromatin landscape at its enhancers to 
facilitate the binding of other transcription factors. Our results therefore highlight the emerging 
role of other transcription factors in regulating the ~15% of genes that are rhythmically expressed 
in a given mammalian tissue, and suggests that clock-controlled gene expression relies more on 
the interplay between the circadian clock and other signaling pathways. Given that the majority of 
CLOCK:BMAL1 target genes are either arrhythmically or not expressed under standard 
conditions, our data also suggest that these non-oscillating genes may become rhythmically 
expressed under other environmental and/or pathological conditions, and thus expand the total 
number of genes under circadian control to more than 50% in mammals 66. Finally, because the 
clockwork mechanisms are highly conserved between eukaryotes (e.g., heterogeneous 
transcriptional output, poor reproducibility between datasets characterizing circadian gene 
expression, regulation of chromatin landscape by core clock components), it is likely that the 
mechanisms we uncovered largely apply to all eukaryotic circadian clocks.  
 
Materials and Methods 
Sequencing datasets and alignment to the mouse genome 
Unless notified below, publicly available datasets used in this paper were downloaded from 
the NCBI or EBI websites in either sra or fastq formats (see Table II-1 for accession numbers). 
Files in sra format were converted to fastq files using the sratoolkit (version 2.3.5-2). Fastq files 
were mapped to the mouse genome (version mm10) using bowtie2 149 or tophat2 150. For all 
datasets, we only considered reads that mapped uniquely to the mouse genome (i.e., one unique 




(rmdup function) or a custom-made script. Additional information is provided for each dataset as 




Table II-1 Public Datasets Used in this Study.  
Reference SRA/GEO dataset Data Remapped 
Koike et al., 2012 7 GSE39977 ChIP-Seq: BMAL1, 
CLOCK, PER1, PER2, 
CRY1, CRY2, H3K27ac 
Yes1 
Menet et al., 2012 12 GSE36916 Nascent-Seq 
RNA-Seq 
Yes2 
Rey et al., 2011 83 GSE26602 ChIP-Seq: BMAL1 Yes 
Cho et al., 2012 89 GSE34020 ChIP-Seq: Reverba, Reverbb Yes 
Menet et al., 2014 13 GSE47145 MNase-Seq Yes3 
Le Martelot et al., 2012 77 GSE35790 ChIP-Seq: RNA polymerase 
II (Pol II) 
Yes 
Vollmers et al., 2012 19 SRA025656 ChIP-Seq: H3K9ac, 
H3K27ac 
Yes 
Fang et al., 2014 90 GSE59486 ChIP-Seq: E4BP4, Roralpha 
GRO-Seq 
Yes4 
Ling et al., 2010 151 GSE21777 DNase-Seq No5 
Faure et al., 2012 99 https://www.ebi.ac.uk/arraye
xpress/experiments/E-
MTAB-941/ 
ChIP-Seq: GABPA, HNF1, 
HNF4A, E2F4, CEBPA, 
HNF6, p300, CBP, CTCF 
Yes 
Lim et al., 2015 100 GSE59752 ChIP-Seq: CEBPB, GR Yes 
Boergesen et al., 2012 101 GSE35262 ChIP-Seq: LXR, PPARa, 
RXR 
Yes 
Gordon et al., 2014 103 GSE52351 ChIP-Seq: ERalpha Yes 
MacIsaac et al., 2010 102 GSE17067 ChIP-Seq: FOXA1, FOXA2 Yes 
Zhang et al., 2012 104 GSE31578 ChIP-Seq: BCL6, STAT5 Yes 
Atger et al., 2015 106 GSE73554 RNA-Seq: Wild-type and 
Bmal1-/- mouse liver 
No6 
Eckel-Mahan et al., 2015 110 GSE52333 Mouse liver RNA expression 
(microarray data) from wild-
type mice fed normal chow 
or high fat diet 
No7 
Vollmers et al., 2009 107 GSE13093, GSE13064 Mouse liver RNA expression 
(microarray data) from wild-
type mice fed ad libitum or 




1 Datasets from Koike et al., 2012 were downloaded as sra files and remapped to the mouse genome (mm10 version) 
to analyze ChIP-Seq signal at various enhancers. However, we used the CLOCK and BMAL1 peak coordinates 
provided in the supplemental table of the original paper to generate our list of high confidence CLOCK:BMAL1 DNA 





2 Nascent-Seq and RNA-Seq dataset were remapped to the mouse genome version mm10 (e.g., to generate the Figure 
II-19). However, Nascent-Seq and RNA-Seq signals were retrieved from the original paper (Figure II-8—source data 
1 and Figure II-9—source data 2) and used to generate the data presented in Figure II-2.  
 
3 While fastq files were remapped to the mouse genome version mm10, further analysis was performed as described 
in the original paper 13. For example, the 50nt reads were extended to 147nt to match the length of a mononucleosome.  
 
4 Analysis of the GRO-Seq dataset has been performed similarly to the original paper and reads were also extended to 
150bp as in Fang et al., 2014 90.  
 
5 No reanalysis of the DNase-Seq was performed. The file GSE21777_M-CM_peaks.txt, which contain the list of 
DNaseI hypersensitive sites (DHS) in the mouse liver, was downloaded from the ncbi website (GSE21777) and the 
DHS peak coordinates (mouse genome version mm9) were converted to mouse genome version mm10 using a liftOver 
tool downloaded from the UCSC genome browser website (conversion resulted in a list of 104,556 DHS peaks). 
 
6 The processed files with intron and exon RNA-Seq signal (fpkm) from wild-type and Bmal1-/- mouse liver were 
downloaded from the ncbi website and directly used to generate the Figure II-16 B and Figure II-16 C (files 
GSE73554_KO_RF_Intron_Exon_RFP.txt and  
GSE73554_WT_RF_Intron_Exon_RFP.txt).  
 
7 Processed microarray data were downloaded from the ncbi website and used to generate the Figure II-16 D-G. The 
original statistical analysis performed by the authors from the journal Cell website was used in our study to assess 
rhythmic gene expression.  
 
 
Identification of CLOCK:BMAL1 DNA binding sites 
Genomic locations of CLOCK and BMAL1 DNA binding sites in the mouse liver provided 
in the original paper 7 were used to generate our list of high confidence CLOCK:BMAL1 DNA 
binding sites. Genomic locations were converted to the mm10 version of the mouse genome using 
UCSC genome browser liftOver tools, and processed as indicated in Figure II-1 to generate our 
list of high confidence CLOCK:BMAL1 DNA binding sites. Overlap between CLOCK and 
BMAL1 ChIP-Seq peaks was determined using bedtools (intersectBed) and coordinates from 
BMAL1 ChIP-Seq datatsets were further kept to generate a list of 3217 CLOCK:BMAL1 peaks. 
We also used the original data provided by the authors to assign CLOCK:BMAL1 peaks to their 
putative target genes (original analysis performed using HOMER tools). In particular, we defined 
a CLOCK:BMAL1 target gene as a gene with at least one CLOCK:BMAL1 peak located between 




criteria, 2458 CLOCK:BMAL1 peaks were assigned to a target gene, and the remaining 759 peaks 
were assigned as an intergenic CLOCK:BMAL1 DNA binding site. 
The 2458 CLOCK:BMAL1 peaks assigned to a target gene were then parsed based on the 
transcription profile of their target genes using the Nascent-Seq datasets from Menet et al., 2012 
12. We directly used the original Nascent-Seq expression values and the assessment of their 
rhythmic expression from the original paper without performing new analysis. Details on how 
genes were determined to be rhythmically transcribed are provided in Supplementary Materials 
and Methods. Using these data, CLOCK:BMAL1 peaks were parsed into 4 different categories of 
transcriptional output (see also Figure II-1):  
(i) Rhythmic transcription in phase with CLOCK:BMAL1 binding (peak of transcription 
between ZT02 and ZT12), 205 CLOCK:BMAL1 peaks, 
(ii) Rhythmic transcription out-of-phase with CLOCK:BMAL1 binding (peak of transcription 
between ZT12 and ZT02), 124 CLOCK:BMAL1 peaks, 
(iii) Arrhythmic transcription, 654 CLOCK:BMAL1 peaks (criteria used to defined arrhythmic 
transcription are detailed in Supplementary Materials and Methods). Note that to decrease the 
number of false positive in the list of arrhythmically expressed genes, we removed genes that 
exhibit arrhythmic nascent RNA expression, but exhibit rhythmic mRNA expression (using the 
RNA-Seq dataset from Menet et al., 2012 12, 
(iv) Not transcribed (average reads/bp between the 12 sample < 1), 291 CLOCK:BMAL1 peaks.  
The remaining peaks, which were not analyzed in this study, were categorized as: 
(v) Post-transcriptional cyclers, 262 CLOCK:BMAL1 peaks. These peaks target genes with an 
arrhythmic Nascent-Seq signal, but rhythmic RNA-Seq signal (based on the reads/bp values 




(vi) Low expression levels, 588 CLOCK:BMAL1 peaks. These CLOCK:BMAL1 peaks target 
genes with Nascent-Seq and/or RNA-Seq signals that are below threshold for the analysis of 
rhythmic expression, but above the threshold of 1 read/bp set to define the “not-expressed” 
CLOCK:BMAL1 target genes. These thresholds were defined in Menet et al., 2012 12. 
(vii) No signal value, 334 CLOCK:BMAL1 peaks. These peaks were assigned to a target gene 
(defined as described above with the HOMER software and localization criteria), but no 
information was found in the Nascent-Seq or RNA-Seq. Several of these peaks target genes 
encoding for a non-coding RNA, as well as genes with alternative gene symbol. 
 The list of the 3217 CLOCK:BMAL1 peaks parsed into the different transcriptional output 
categories can be found in S1 Table from Trott and Menet, 2018. The phase of rhythmic 
CLOCK:BMAL1 DNA binding, ChIP-Seq signal, and genomic location of CLOCK:BMAL1 
DNA binding sites were retrieved from the Koike et al., 2012 original paper supplementary 7 and 
processed to generate the analysis presented in Figure II-2.  
 
Analysis of ChIP-Seq, MNase-Seq and GRO-Seq signal at CLOCK:BMAL1 peaks 
ChIP-Seq, MNase-Seq and GRO-Seq signal was retrieved from bam files containing 
uniquely mapped reads (and duplicated reads removed) at CLOCK:BMAL1 enhancers using 
custom-made scripts 13. Specifically, signal was retrieved at: 
- CLOCK:BMAL1 peak center ± 250 bp for transcription factors, CBP, 300 and Pol II,   
     - CLOCK:BMAL1 peak center ± 1kb for histone modifications,   
     - CLOCK:BMAL1 peak center ± 500 bp for eRNA, 




and normalized to the sequencing depth. Differences in the window size were calculated based on 
the width of the ChIP-Seq signal at CLOCK:BMAL1 DNA binding sites (e.g., H3K27ac ChIP-
Seq signal is significantly wider than any transcription factor ChIP-Seq signal). Because we aimed 
at assessing the role of CLOCK:BMAL1 in removing a nucleosome at its DNA binding site, we 
chose a narrower window size of 150bp (see Figure II-9 A-D). All analyses were performed at 
individual CLOCK:BMAL1 ChIP-Seq peaks, and this even for peaks targeting the same gene. 
Data presented in Figure II-5 examined the role of multiple peaks targeting the same gene on 
BMAL1 and CLOCK ChIP-Seq signals. For all datasets, ChIP-Seq signal is displayed as the 
number of reads/bp per 100,000,000 reads.  
 
Analysis of ChIP-Seq and GRO-Seq signal at other enhancers targeting CLOCK:BMAL1 target 
genes 
 Enhancers lying into CLOCK:BMAL1 target gene loci (-10kb from the transcription start 
site to +1kb from the transcription termination site) were identified using a public mouse liver 
DNAse-Seq dataset (see above) 151 and bedtools (intersectBed function). Enhancers were then 
parsed based on the presence or not of a CLOCK:BMAL1 ChIP-Seq peak (3155 out of the 3217 
CLOCK:BMAL1 ChIP-Seq peaks are located into a DNaseI hypersensitive site). Because a 
majority of the 104,556 DHS peaks only displayed low levels of ChIP-Seq (transcription factors, 
Pol II, H3K27ac) and GRO-Seq signals as shown in the ENCODE project, 152,153, we filtered the 
number of DHS lying into a CLOCK:BMAL1 target gene by only considering those being into the 
top 40,000 DHS list (based on DNase-Seq signal), obtaining the following number of DHS peaks:  
(i) In-phase transcription cyclers: 1548 DHS peaks, 




(iii) Arrhythmically expressed target genes, 5830 DHS peaks, 
(iv) Not expressed target genes, 991 DHS peaks.  
 H3K27ac and Pol II ChIP-Seq signals, as well as GRO-Seq (eRNA) signal, were retrieved 
at those DHS sites (as well as those overlapping with a CLOCK:BMAL1 peak) using the DHS 
peak coordinate and normalized to 100,000,000 reads. Signal was then normalized to the 
coordinate length (in bp) to obtain the signal displayed as reads/bp per 100,000,000 reads. The 
coordinates used were, for the same reason as above for CLOCK:BMAL1 DNA binding sites: 
     - H3K27ac ChIP-Seq: DHS genomic coordinate center ± 1 kb,  
     - Pol II ChIP-Seq: DHS “real” genomic coordinates, 
     - GRO-Seq (eRNA signal): DHS genomic coordinate center ± 500 bp. 
Because our analysis revealed the existence of small but significant overall variations of 
H3K27ac and Pol II ChIP-Seq signal between time points (see Figure II-11), we further normalized 
the datasets by performing either a mean normalization (H3K27ac) or a ranking analysis (Pol II). 
For H3K27ac ChIP-Seq datasets 7,19, averaged H3K27ac signal was calculated at the top 40,000 
DHS peaks (the top 40,000 DHS peaks concentrate the majority of TFs DNA binding sites; peak 
center ± 1 kb; total of 104,556 total DHS peaks; dataset from Ling et al., 2010 151) for each time 
point. This averaged signal was then used to normalize the raw H3K27ac ChIP-Seq signal, by 
calculating for each time point the ratio between H3K27ac signal for each peak and this averaged 
signal (see Figure II-11). Pol II ChIP-Seq dataset 77 were normalized by performing a ranking 
normalization (method similar to a quantile normalization). To this end, Pol II ChIP-Seq signal 
was calculated at all 104,556 DHS peaks (peaks mapped in Ling et al., 2010 paper 151), and sorted 
based on the ChIP-Seq values. The raw values for each DHS peak were then normalized using the 





Motif analysis was performed at CLOCK:BMAL1 enhancers (original peak coordinates) 
for each of the transcriptional categories using the findsMotifGenome.pl script from the HOMER 
suite. Parameters were as the following: -size given –len8. The resulting table was sorted by the 
q-value and a q-value less than 0.05 was considered significant. Percent enrichment (percent of 
target sequences with motifs / percent of background sequences with motif) was then calculated 
for motifs found to be significant in at least one of the CLOCK:BMAL1 transcriptional output 
category.  
 
Determination of the TF DNA binding variability index 
To determine the variance of each TF DNA binding (CLOCK, BMAL1, ts-TFs and u-TFs) 
between the four CLOCK:BMAL1 transcriptional output categories, we computed a TF DNA 
binding “variability index” based on the analysis performed in Figure II-14. The variability index 
was calculated by summing up the standard deviation of the ChIP-Seq signal between the 4 
transcriptional output groups, which was calculated for each decile (0.1 to 0.9) and normalized to 
the averaged signal for each decile (the standard deviation is higher for upper deciles because 
ChIP-Seq signals are higher). This index reflects differential DNA binding strength between 
groups, as similar binding between the 4 groups results in small standard deviation values for each 
decile, and thus a small variability index. Conversely, differences in DNA binding signal between 







Generation of a list of control genes not targeted by CLOCK:BMAL1  
To determine if the results described in this paper are specific to CLOCK:BMAL1, we also 
performed an analysis on genes not targeted by CLOCK:BMAL1, but exhibiting similar profiles 
of expression to the 4 CLOCK:BMAL1 transcriptional output categories (Rinφ, Ro/φ, AR and 
NE). To this end, 125 genes were randomly selected for each of the 4 groups, using criteria similar 
to those used to define CLOCK:BMAL1 transcriptional output (see above). Levels of expression 
for each group were not significantly different to those of CLOCK:BMAL1 target genes (Kruskal-
Wallis test). Nucleosome signal, H3K27ac ChIP-Seq signal, Pol II ChIP-Seq signal, eRNA 
expression, tissue specific and ubiquitous transcription factor ChIP-Seq signal were all calculated 
as described above for CLOCK:BMAL1 target genes. Statistical analysis was also performed 
similarly to CLOCK:BMAL1 transcriptional output.  
 
Statistical analysis 
Statistical analysis was done using JMP®, Version Pro 12.0.1. SAS Institute Inc., Cary, 
NC, 1989-2007. Differences in sequencing signal, represented in the boxplot graphs, were 
analyzed for statistical enrichment using the nonparametric Kruskal-Wallis test. Rhythmic analysis 
of nucleosome signal and ChIP-Seq signal was performed using a Fourier analysis (Figure II-9 A-
D) (see Supplementary Materials and Methods for details). Differences in the amplitude of 
nucleosome signal rhythm (Figure II-9 E) were analyzed using a 2-way ANOVA. Differences in 
CLOCK:BMAL1 ChIP-Seq peaks genomic location were analyzed using a chi-square test (Figure 
II-2 G), and differences in the number of CLOCK:BMAL1 peaks per target genes (Figure II-6) 





CHAPTER III  
MOLECULAR CHARACTERIZATION OF THE EFFECTS OF SHIFT WORK AND FOOD 
CONSUMPTION ON CARDIOVASCULAR DISEASE IN THE RAT  
 
Overview 
Shift work misaligns the circadian clock and leads to an increased risk of cancer, 
cardiovascular diseases, and metabolic disorders. Furthermore, food consumed during the rest 
phase is a major contributor to this misalignment, as food access restricted to the endogenous 
active phase, at night, prevents against the adverse effects of shift work on obesity and diabetes in 
rats. In this study, we aimed to investigate the molecular mechanisms by which shift work and 
food consumption contribute to an increased risk of cardiovascular disorders. To this end, we used 
a model of shift work in rats, whereby animals are exposed to a 12:12 light:dark cycle and are 
forced to be active for eight-hours during their natural rest phase during the day, Monday to Friday 
for five consecutive weeks. Given the preventive effects of temporal restriction of food intake, a 
group of shift worker rats with food access restricted to the night was included in addition to 
controls and shift workers. To gain insight into the molecular underpinnings of shift-work 
associated cardiovascular pathologies, we performed Picrosirius Red staining and RNA-Seq 
analysis in rat hearts. Our results show that shift work rats, regardless of the time of food 
consumption, have an increase in collagen deposition in the heart. In addition, the expression of 
many genes encoding key fibrotic pathways were found to be up-regulated in shift worker rats that 
had their food restricted to the active phase. Altogether, our results suggest that five weeks of shift 
work in rats is capable of inducing cardiovascular disease through an up-regulation of collagen 





Shift work is a work schedule that has been defined many times as being any work done 
outside the general working hours during the day 35. This type of work schedule is becoming 
increasingly popular among employers to meet the high demand of productivity in modern society. 
Many of these industries including manufacturing, agriculture, transportation, healthcare and 
emergency services require some form of shift work. This has been reported to be approximately 
15-30% of workers in America and Europe, and this work force is rapidly increasing 34. Shift work 
has been reported to disrupt many aspects of one’s lifestyle including job strain and social stress. 
Furthermore, shift work has been correlated with an increased risk of pathological diseases such 
as cancer, cardiovascular disease, and metabolic disorders like obesity and diabetes 34-36,39.  
Numerous studies have been conducted that have correlated shift work with cardiovascular 
disease. A meta-analysis was done in 1999 on 17 studies observing the risk of shift work and 
cardiovascular disease, concluded that shift workers have a 40% increased risk of cardiovascular 
disease compared to day workers  35. However, significant heterogeneity has been found among 
these results and thus it is still unknown how the quantity and duration of shift work affect 
cardiovascular disease 34.  
The exact mechanisms on how shift work causes cardiovascular disease is unknown, 
however many mechanisms have been hypothesized 35. Additionally, shift work is known to alter 
the circadian clock and food consumption, all of which have been correlated to cause metabolic 
disruption and diabetes 36. Furthermore, both of these have been known to contribute to 
cardiovascular disease by increasing the load that the heart must work under which can lead to an 
accumulation of myocardial fibrosis 154,155. Almost all cardiovascular disease is associated with 




extracellular matrix of the heart 155,156. Persistent presence of stress conditions will result in a 
continual deposition of collagen and extracellular matrix proteins resulting in fibrosis. The TGF-
β signaling pathway has been recognized as one of most potent profibrotic cytokines known to 
stimulate fibrosis, via myofibroblast differentiation and extracellular matrix remodeling 51,52,157,158.  
To uncover the mechanisms on how shift work causes cardiovascular disease, we used a 
shift work model developed in rats to mimic the conditions of a human night shift worker. Our 
data revealed that five weeks of shift work induces an increase in collagen deposition in the rat 
heart. This induction of collagen deposition is irrelevant to time of day eating and thus suggests 
that the act of shift work alone is sufficient to increase collagen deposition in the heart. 
Surprisingly, we observed very little differential gene expression between the Worker and Control 
rats. However, we observed a significant change in differential gene expression for rats forced to 
do shift work during the day but had their food consumption restricted to the night. Furthermore, 
we observed that many of these differentially expressed genes were found in pathways associated 
with fibrosis and hypertrophy. Altogether, our results suggest that shift work is capable of inducing 






Shift work induces collagen deposition in the heart 
To determine the molecular mechanisms by which shift work and food consumption 
contribute to cardiovascular disease we used a rat shift work model (Figure III-1 A, B). A total of 
54 rats were maintained on a 12:12 light dark cycle (7am to 7pm) and then randomly assigned to 
Control (C), Worker (W), or Worker Restricted Feeding (WRF) groups. Shift work consisted of 
rats being placed in a slowly rotating drum (1rev/3min) as published previously by Salgado-
Delgado et al., 2010. Control rats had access to ad libitum food and water throughout the 
experiment. Worker rats had access to ad libitum food and water but were forced to do shift work. 
Worker Restricted Feeding rats were also forced to do shift work, had ad libitum access to water, 
but only had access to food when not doing shift work. W and WRF rats were forced to do 
shiftwork Monday-Friday and were given the weekend off where they were fed and watered like 
C. Rats maintained this paradigm for five weeks before rats were euthanized and hearts were 







Figure III-1 Shift Work Paradigm. 
A, B. Rats individually housed and maintained on a 12 hour light: 12 hour dark schedule were randomly assigned to one of the three groups: Control 
(C), Worker (W), or Worker Restricted Feeding (WRF). All rats had ad libitum access to water. C rats had ad libitum access to food and were not 
moved from their cages. W and WRF rats were placed in a rotating drum (1 revolution/3min) for eight hours Monday- Friday to simulate shift 
work, and were left in their cages over the weekend. W rats had ad libitum access to food at all times, including in the wheel, while the WRF rats 






 Increases in collagen deposition have been well established as a marker of fibrosis and 
cardiovascular disease 159-161. To investigate if shift work increased levels of fibrotic tissue in the 
heart, we conducted Picrosirius Red staining on cryostat sections of our C, W, WRF rat hearts. 
Following the staining of these 54 samples, we conducted a blind study to determine if there were 
differences in collagen deposition between the different paradigms (Figure III-2 A). A score of 
zero was given for no collagen deposition and maximum collagen deposition was given a score of 
four. The blind study resulted in significantly higher score for W and WRF compared to C, 
indicating that five weeks of shift work results in more collagen deposition in the rat heart (Figure 






Figure III-2 Shift Work in Rats Causes Fibrosis in the Heart.  
A. Representative examples of Picrosirius red stained rat 10 μm myocardial sections for scoring of the blind study. A score of 0-4 was given for 
collagen deposition. Yellow =viable myocardium, and red = collagen. B. Boxplot of blind scoring of 18 samples per group conducted by four 





 These results suggest that five weeks of shift work is enough time to induce larger amounts 
of collagen deposition in the heart. Additionally, they suggest that eating during the natural active 
phase at night does not inhibit shiftwork induced collagen deposition in the rat heart.  
 
Gene expression is significantly altered in WRF 
To further assess if we were observing cardiovascular disease in W and WRF rats, we 
sequenced the transcriptome of C, W, WRF rat hearts. This consisted of 18 biological replicates 
per group with a median seq depth of 25 million reads per sample. Gene expression was mapped 
to RN6 using Tophat2 and further analyzed using Cufflinks 162,163. As previously published, a 




(RPKM) 164. To remove any false positives, we chose to keep genes that where expressed in 18 of 
the 54 biological samples with a log2 (fpkm+1) value over 1. This left us with 10,257 total genes 
expressed in C, W, WRF hearts. To determine differential gene expression, we did a one-way 
ANOVA with post-hoc Tukey’s HSD (p-value <0.05) analysis on C, W, WRF. Categories of 
significantly differentially expressed genes are illustrated by bar graphs with the total number of 
genes written on top of the graph in Figure III-3 A. Majority of the genes found to be differentially 
expressed are up-regulated or down-regulated in WRF compared to both W and C groups, which 
we have labeled as Categories 1A, 1B, 2A, and 2B (Figure III-3 A). Strikingly, only six genes 
were found to be significantly up or down regulated in both W and WRF compared to C. Although, 
approximately 600 genes were found to be significantly differentially expressed between W and 








Figure III-3 Shift Work and Restricted Feeding Significantly Alters Gene Expression in the Rat Heart.  
A. Differential gene expression was analyzed with a one-way ANOVA on paradigms with post hoc analysis using Tukey’s HSD. Genes were 
considered as differentially expressed between paradigms with a p-value < 0.05. Categories of statistically significant differential gene expression 
are illustrated by bar graphs with the total number of genes written above for each category. Groups with different letters are significantly different 
with a Tukey’s HSD p-value <0.05. The majority of the genes were either up-regulated (Categories 1A, 1B, 3) or down-regulated (Categories 2A, 





Heatmap visualization of the differences in standardized gene expression in these 
categories illustrates the individual biological variation in gene expression; however, the over-all 
trend of up or down regulation of gene expression for each group is easily observed between the 




ribosome and proteasome pathways in category 1A, as well as an enrichment of NF-kappa B 
signaling pathway, AMPK signaling pathway, and PPAR signaling pathway in categories 1B and 
3 (Figure III-4 C). Furthermore, categories 2A, 2B, and 4 were enriched for the FoxO signaling 
pathway, mTOR signaling pathway, ErbB signaling pathway all which have been suggested to be 
involved in remodeling of the extracellular matrix of the heart leading to fibrosis and 





Figure III-4 WRF Significantly Upregulates Gene Expression for Ribosomes, Proteasomes, and Metabolic 
Pathways. 
A. Heatmap of standardized gene expression for categories 1A, 1B, 2A, 2B, 3, and 4 genes, n=18 animals per paradigm sorted by time of euthanasia. 
Yellow indicates up-regulation, while blue indicates down-regulation. B. KEGG pathway analysis of the differentially expressed Categories 1A 





Collagen and fibroblast marker gene expression is significantly up regulated in WRF 
To understand the large differences in collagen deposition in W and WRF, we looked at 
collagen gene expression. Interestingly, the only genes that were significantly differentially 
expressed were collagen type 1 alpha 1 chain (Col1a1) and collagen type 1 alpha 2 chain (Col1a2), 
which were expressed at a greater level in WRF (Figure III-5 A). Additionally, an increased 
expression of these genes has been linked to remodeling the cardiac matrix, leading to fibrosis and 
cardiac disease 169. 
To investigate if the increase in collagen deposition observed in W and WRF is because of 
an increase in fibroblasts, we looked at fibroblast marker gene expression. Again, we observed 
that WRF was the only group with a significant differential gene expression of fibroblast markers, 
fibroblast-specific protein-1 (s100a4) and Thy-1 cell surface antigen (Thy1), were significantly 
up-regulated in WRF compared to C and W (Figure III-6 A). Surprisingly, W rats did not show 
up-regulation for any markers of fibroblasts, which are predominantly the manufactures of 












Figure III-5 Some Collagen Genes are Up-Regulated in WRF Rats. 









Figure III-6 Only Two Fibroblast Markers are Up-Regulated in WRF Rats. 






As shown previously, W and WRF rats have an increased deposition of collagen between 




This lack of a significant increase in gene expression for our W group brings to question what is 
up-regulating collagen deposition in our W rat hearts.  
 
Open chromatin regions reveal fibrotic transcription factor motifs 
ENCODE consortium revealed that ~95% of transcription factors bind in open chromatin 
regions 170. To understand the mechanisms behind the differential gene expression observed 
between the different paradigms, we set out to find the transcription factors responsible for 
activating or repressing this transcription. We conducted DNase-Seq in the rat heart to discover 
where the open chromatin areas were and what transcription factors may be binding to alter this 
gene expression. To validate our DNase-Seq in the rat heart, we overlapped our peaks with those 
of ENCODE’S mouse DNase-Seq peaks 170. Overall, with strict peak calling, we had a 76% 
overlap of our rat rn6 enhancers to the mouse mm10 enhancers (Figure III-7 A). Figure III-7 B is 
an IGV browser of the comparison of DNase-Seq mapped reads to Nr1d1 and Col1a1 genes, and 
is an example of the synteny and the differences of enhancers found between rat and mouse. The 
yellow boxed peaks illustrated in Figure III-7 B are examples of  peaks that were further 
analyzed using HOMER motif analysis to discover transcription factors that might be altered by 
shift work 171-173.   
We conducted our motif analysis using HOMER on open chromatin regions observed 10kb 
up-stream of transcription start sites (TSS) and 1kb down-stream of transcription termination sites 
(TTS) of the genes found in categories 1A, 1B, 2A, 2B, 3, & 4 173. We found a significant 
enrichment of transcription factor motifs associated with transcription factors that have been 
correlated with fibrosis and cardiovascular disease in the heart for differentially expressed genes 




Figure III-7 Shared Synteny Between DHSs in the Mouse and Rat. 
(A) Rat DNase-Seq peaks were converted to mouse mm10 genome with LiftOver and then overlapped with mouse DNase hypersensitive sites 
(DHS) from the ENCODE project to observe synteny between genomes. 76% of the lifted-over rat DHS overlapped with the mouse ENCODE 
dataset. (B) IGV browser visualization of rat DNase-Seq reads and mouse DNase-Seq reads for Nr1d1 and Col1a1. DNase-Seq peaks are boxed in 












Figure III-8 Motif Analysis of DHS in Genes Found in Differentially Expressed Categories. 
HOMER motif analysis of DHS within genes found in categories 1A_1B, 2A_2B, 3, and 4. Motifs with a p-value < 0.05 are colored from yellow 







In summary, our rat DNase-Seq open chromatin regions overlap well with the ENCODE’S 
mouse DNase-Seq open chromatin regions. Furthermore, our motif analysis identified 
transcription factors known to cause fibrosis and suggests that they may be altering our differential 
gene expression observed between our paradigms. Importantly, our open chromatin regions and 
RNA-seq show an enrichment for the same pathways and transcription factors that may be being 
altered to initiate cardiovascular diseases in shift workers.  
 
Fibrosis mechanisms cannot be fully explained with gene expression 
Several mechanisms may be contributing to the collagen deposition we are observing in W 
and WRF. Previous studies have demonstrated that the transforming growth factor beta (TGF-β), 
epidermal growth factor (ErbB), insulin signaling (INSR), and solute carrier family 2 facilitated 
glucose transporter (GLUT) pathways can be responsible for activating fibroblasts leading to 








Figure III-9 Proposed Model of How Shift Work and Shift Work Restricted Feeding May Increase Fibrosis 
through Multiple Signaling Pathways. 
A. Pathway schematic of how shift work leads to increased collagen and fibrosis in the heart. Shift work promotes the activation of the TGF-β, 
ErbB, and INSR pathways. TGF-β pathway initiates the activation of TIMPs which stimulates collagen deposition. TGF-β, ErbB, and INSR 
pathways all activate PI3K which in-turn activates mTOR, MEK, and AKT. mTOR and AKT are involved in up-regulation of translation and MEK 





One of the most important factors for regulating the transition of epicardial cells to 
fibroblasts is the TGF- β pathway 44. Strangely enough, we do not observe a significant change in 
gene expression of transforming growth factor beta receptor (Tgfr1), but we do observe a 
significant up-regulation of gene expression of TIMP metallopeptidase inhibitor1 (Timp1) in WRF 
(Figure III-10 A). Timp1 is up-regulated when the TGF- β pathway is up-regulated and is 
responsible for inhibiting metalloproteinases and in the process stimulates collagen deposition and 




deposition 169. Up-regulation of the TGF- β pathway is considered a master switch in its ability to 
induce other downstream profibrotic mediators such as ErbB, INSR, and GLUT 51. However, 
regulation of the other pathways has been shown to independently mediate enhanced collagen 
production in fibroblasts 51,179. We observed that expression of Erb-B2 receptor tyrosine kinase 2 
(Erbb2) is not significantly differentially expressed between the three paradigms. However, we do 
observe differences in expression of phosphatidylinositol-4,5-bisphosphate 3 kinase (PI3K)’s 
catalytic and regulator subunits, as well as, insulin receptor (Insr), insulin receptor 
substrate1(Irs1), and insulin receptor substrate 3 (Irs3). Surprisingly, we do not see differences in 








Figure III-10 WRF Alters the Expression for Some of the Genes Involved in Activation of Fibrosis. 
A. Boxplots of gene expression for genes involved in multiple signaling pathways in the Figure III-9A. Groups with different letters are significantly 






Together these results suggest that shift work induces collagen deposition in the heart, even 
when eating has been shifted to the natural active phase. Additionally, these pathways may be 
playing a role in the collagen deposition in the W and WRF. However, gene expression alone may 
not be sufficient to explain differences in collagen deposition between the paradigms, which 
suggests that shift work mediated regulation of these pathways may be post-transcriptional instead 
of transcriptional.  
 
Discussion  
Shift work has been strongly correlated with cardiovascular disease and it has been 
suggested that shift workers have a 40% increase in cardiovascular disease compared to day 
workers. Furthermore, the mechanism underlying how shift work is causing cardiovascular disease 
is unknown 41,180. In our experimental model, using rats that are forced to be active during the day 
(W) and rats that are forced to be active during the day but only allowed to eat during the night 
(WRF), we show that shift work causes an increase in collagen deposition in the heart for both W 
and WRF groups. This is surprising because we provide the first evidence of how shift work may 
be causing cardiovascular disease and, furthermore, that time of eating does not seem to inhibit 
this effect in the heart. These findings are contradictory with what has been previously published 
for shift work and metabolic disorders, such that eating during the natural active phase while doing 
shift work is sufficient to inhibit metabolic disorders, such as obesity and diabetes 36,181.  
To address the mechanism behind how shift work is inducing an increase in collagen 
deposition in both W and WRF, we characterized, for the first time, the transcriptome of C, W, 
and WRF rat hearts. Surprisingly, we found a significant difference in gene expression for WRF 




gene expression of mice that had pathological hypertrophy compared to mice that had 
physiological hypertrophy, suggesting that more pathways are significantly altered in hearts 
undergoing heart failure. Additionally, genes that were up regulated in our WRF rats were 
significantly enriched for ribosome and proteasome KEGG Pathways. This suggests that there may 
be an up-regulation in proteins, which previous publications have found to be an early marker of 
heart disease and is needed for increased proteins found in pathological hypertrophy 182,183. In this 
regard, it is of great interest and importance to further study these changes that we observed for 
gene expression, and how they translate to changes in protein expression. Furthermore, we found 
NF-kappa B signaling, AMPK signaling, PPAR, FoxO, mTOR, and ErbB signaling pathways to 
be differentially expressed in our W and WRF rats. These pathways when altered have been 
attributed to cause fibrosis, hypertrophy, and heart failure 54,184,185.  
Investigation of transcription factors that may be recruited to these differentially expressed 
genes revealed an enrichment of motifs for transcription factors that regulate connective tissue 
growth factor (CCN2) which is essential in regulating angiogenesis, chondrogenesis, and wound 
healing 176. Friend leukemia integration 1 (FLI1) and ETS proto-oncogene 1 (ETS1) were both 
found in enhancers surrounding genes that are up-regulated in WRF, and both have been found to 
regulate extracellular matrix genes such as Collagen type 1. Additionally, we found Kruppel-like 
factors (KLF) motifs surrounding many of the differentially expressed genes and these have been 
implicated in many cellular processes such as glucose homeostasis and cardiac hypertrophy 177. In 
particular, KLF5 has been reported to play a role in cardiovascular remodeling through TGF-β 
pathway 186. 
On a cellular level the heart is composed of cardiac myocytes, fibroblasts, endothelial cells, 




types of stresses, cardiac myocytes increase their functional load, activating signaling pathways 
by changing gene expression, increasing protein synthesis, and increasing collagen deposition 188. 
In response to this increase in functional load, the heart mass will increase to try and normalize 
wall stress. This enlargement of cardiac muscle cells is referred to as cardiac hypertrophy. 
Additionally, this increase in heart mass typically occurs in the ventricles. If equilibrium cannot 
be reached the hypertrophied heart can dilate and contraction of the myocytes fails  occur 
progressing in heart failure 154. We observe an increase in ribosome subunit expression as well as 
an enrichment of the KLF motif for genes that were differentially expressed in W and WRF rats. 
This data implicates that cardiac hypotrophy is occurring; however, further research needs to be 
done to see if there is an increase in heart or cardiac myocyte size for W and WRF rats compared 
to C.  
Many animal studies have been done to try and discover the molecular mechanisms that 
occur in pathological hypertrophy, however not all of these have been done without contention. 
Collagen 1 and collagen 3 are always found with pathological hypertrophy, and this is what we 
found in our W and WRF rat hearts. This deposition of collagen is produced by fibroblasts to 
replace myocytes that undergo apoptosis 53,159,184,189. Furthermore, many signaling pathways such 
as TGF-β, ErbB, and INSR have been attributed to lead to fibrosis and hypertrophy 51,155. The 
TGF- β signaling pathway, in particular, is responsible for inhibiting expression of matrix 
metalloproteinases (MMPs), needed to degrade extracellular matrix proteins, and activating of 
tissue inhibitors of metalloproteinases (TIMPs), which inhibit MMPs. It is this disturbance in the 
balance between the MMPs and TIMPs that allow for accumulation of collagens in the 
extracellular matrix 53. More specifically, our data also shows an increase in Timp1 gene 




multifunctional cytokine that plays an important role in proliferation, differentiation, and apoptosis 
by signaling through PI3K to mTOR, MEK, AKT155. Furthermore, signaling through ErbB and 
INSR pathways also feed into PI3K and are essential for myofilament structure, glucose uptake, 
and angiogenesis 54,55. Surprisingly, our gene expression data is unclear on whether these pathways 
are being altered or not by shift work. Further analysis is needed to observe if post-transcriptional 
mechanisms are occurring in W and WRF rats to affect these pathways and to cause the increase 
in collagen deposition in W and WRF rats.  
In conclusion our data suggests that five weeks of shift work, independent to time of eating, 
induces an increase in collagen deposition in the rat heart. Furthermore, eating at night during the 
natural active phase is not sufficient to inhibit collagen deposition. Astonishingly, we observe 
significant differential gene expression in WRF compared to W and C. Genes that are up-regulated 
in WRF are enriched for ribosome, proteasome, NF-kappa B, AMPK, and PPAR signaling 
pathways. Open chromatin regions surrounding genes found to be differentially expressed were 
found to be enriched for transcription factors found to be involved in fibrosis and cardiovascular 
disease. Surprisingly, we only observe an increase in expression of collagen genes and fibroblast 
markers in WRF and not W when compared to C. Our results indicate that gene expression alone 
is not sufficient to explain collagen deposition and that post transcriptional mechanisms must be 
occurring. Further studies will be needed to precisely verify the molecular pathways in which shift 










Male Wistar rats around the age of 7-8 weeks underwent a shiftwork protocol for five 
weeks. Each animal was housed individually in a 12 L:12 D cycle (7am to 7pm) throughout the 
protocol. Protocol consisted of 54 animals randomly assigned to three groups: 18 Controls ‘C’ 
(undisturbed and no shiftwork protocol, ad libitum food and water), 18 Workers ‘W’ (shiftwork 
protocol, ad libitum food and water), 18 Worker Restricted Feeding ‘WRF’ (shiftwork protocol, 
ad libitum water, access to food only at night). Shiftwork protocol consisted of five days of 
scheduled ‘work’ (workday: Monday to Friday, 9am to 5pm) followed by two days without ‘work’ 
and given ad libitum food and water (weekend: Saturday and Sunday). Experiments were approved 
by Universidad Nacional Autonoma de Mexico, in accordance with animal handling, Norma 
Oficial Mexicana NOM-062-ZOO-1999. 
 
Shiftwork protocol 
In order to simulate shiftwork, rats were placed in a slowly rotating drum that were 
designed to keep the animal awake during their natural rest phase or when lights were turned on. 
Drums rotated with a speed of one revolution/three minutes, this was done to allow animals to 
move, eat, and drink freely. However, animals were not able fall asleep; forcing the animals to 
stay awake but not requiring them to exhibit laborious movements. Food and water were hung 
from a concentric middle tube and available depending on which group the rats were placed in. 
Outside of work periods rats were housed in their individual cages with ad libitum food and water 





Heart Tissue Collection 
Rats entrained on 12:12 LD and after five weeks of shiftwork protocol were sacrificed 
every four hours starting one hour after lights turned on at 7am. This was done to account for any 
time of day effects. Heart tissue was collected and flash frozen and then shipped to Texas A&M 
University.   
 
Whole transcriptome sequencing (RNA-Seq) 
RNA was isolated from crushed frozen heart samples using Trizol reagent according to the 
manufacturer’s instructions (Life Technologies). Total RNA was diluted to 4μg and ribosomal 
RNA was depleted using Dyna oligo dT beads following manufacturer’s instructions (Invitrogen). 
Sequencing libraries were constructed using NEB Utra Directional RNA Library Prep Kit from 
Illumina (New England BioLabs) following manufacturer’s instructions (n=54). Total intact RNA 
was fragmented for 15 mins at 94 ͦ C before first and second strand cDNA synthesis. Purification 
of double stranded cDNA was done using AMPure XP beads following NEB Ultra Directional 
RNA Library Prep Kit instructions. PCR library enrichment was amplified for 13 cycles and 
following clean up were quantified by Quantus Fluorometer (# E6150, Promega) and qPCR with 
TRUseq library standards. Libraries were generated with multiple bar-coded adaptors, mixed in 
equimolar ratio and sequenced on three lanes of an Illumina NextSeq with a sequencing length of 
76bps.  
DNase-sequencing 
Nuclei was isolated from crushed frozen heart samples (n=2) using a dounce homogenizer 
in lysis buffer (0.32M sucrose, 10mM Tris-HCl ph8, 5mM CaCl2, 5mM MgCl2, 2.0mM EDTA, 




Homogenate was mixed with sucrose lysis buffer (2.2M sucrose, 10mM tris HCl ph8, 5mM CaCl2, 
5mM MgCl2, 2.0mM EDTA, 0.5mM EGTA, 1mM DTT) and then layered on top of sucrose 
cushion (2.05M sucrose, 10% glycerol, 125mM glycine, 10 mM HEPES pH7.6, 15 mM KCl, 2 
mM EDTA, 1mM PMSF, 0.15mM spermine, 0.5mM spermidine, 0.5mM DTT) in an 
ultracentrifuge tube. Samples were centrifuged for 45 min at 24,000 rpm (100,000g) at 2°C in a 
Beckmann SW28 rotor. Supernatant was removed and nuclei were washed in resuspension buffer 
(10 mM Tris, pH 7.5, 150 mM NaCl, 2 mM EDTA, 1mM PMSF) 3x and then counted and 
aliquoted to tubes of five million nuclei and flash frozen. Flash frozen nuclei were thawed and 
nuclei were pelleted and supernatant was removed before tubes were digested with DNase I 
digestion buffer (6mM CaCl2, 75mM NaCl2, 13.5mM Tris-HCl ph8, 13.5mM NaCl, 54mM KCl, 
0.9mM EDTA, 0.45mM EGTA, 0.45 spermidine) and 80units/ml of DNase I enzyme. Following 
digestion, equal volumes of stop buffer (50mM Tris-HCl ph8, 100mM NaCl, 0.1% SDS, 100mM 
EDTA, 1mM spermidine, 0.3mM spermine) were added to each tube and then incubated at 55°C 
for 1 hour. RNA was removed by adding 10mg/ml of RNase A and samples were incubated at 
37°C for 30 minutes. Samples were purified by phenol/chloroform extraction and then 
resuspended in water. DNA size fractionation was done using a sucrose gradient and centrifuged 
for 30,000 rpm for 20 hours at 20°C in a SW-41 rotor with no brake and minimum acceleration. 
DNA fractions with a size less than 500bps were kept and pooled together for purification and 
concentrated using sodium acetate and ethanol and were resuspended in water. DNase-Seq 
libraries were generated using NEBNext® ChIP-Seq Library Prep Master Mix Set (# E6240, NEB) 
as per the manufacturer’s instructions. DNA collected from the DNase I digestion was quantified 
using the Quantus Fluorometer (# E6150, Promega), and 10 ng was used to generate the libraries. 




oligonucleotides and Phusion Taq (M0530S). Any adaptor dimers were removed using a gel 
purification and phenol chloroform and ethanol precipitation. Libraries were quantified using 
TRUseq library standards and qPCR before paired-end sequencing was done with an Illumina 
NextSeq at a read length of 75bps.  
 
Alignment of RNA-Seq to the RAT (rn6) and differential gene expression analysis 
Libraries were sequenced to a median depth of ~25 million reads /sample and mapped to 
rn6 with an average Tophat2 alignment of ~90% using the following criteria: --read-realign-edit-
dist 2 -g 1 --b2-sensitive 162. Gene expression was analyzed using Cufflinks with the following 
criteria: --library-type fr-firststrand 163. Visualization of the forward and reverse strands were done 
using a custom shell script with total signal normalized to 10 million reads and viewed with the 
Integrated Genome Viewer 171. Genes where 18 of the 54 biological samples had a log2 (fpkm+1) 
value over 1 were kept for further processing (75% of the total number of genes). Differential gene 
expression was done using a one-way ANOVA on shiftwork groups. Post hoc analysis was 





Alignment of DNase-Seq to the RAT (rn6) and motif analysis 
Libraries were sequenced to a median depth of ~ 36 million and mapped to rn6 with an 
average bowtie2 alignment of ~ 85% using the following criteria: -t –phred33 -X 650 191. Sam files 
were converted to bam files and merged using SAMtools view, sort, and merge 192. Duplicates 
were removed with Picard 2.8.2 MarkDuplicatesWithMateCigar created by the Broad Institute. A 
custom python script was used to remove unpaired reads, unmapped reads, and filled in sequences 
between paired-end reads. Sorted coordinates were then made into BWfiles using Bedtools, 
normalized to 10 million reads and viewed with the Integrated Genome Viewer 171,193.  Peak calling 
was done using findPeaks from the HOMER suite using the following commands: -size 45 -
ntagThreshold 2 -region 194. Open chromatin regions for genes of interest were determined by 
using HOMER gene annotation and annotation for these genes were extended 10kb from 
transcription start sites and 1kb from transcription termination sites. These gene windows were 
overlapped with DNase-Seq reads using intersectBed from Bedtools suite193. Motif analysis was 
done on these overlapped files using the perl script findMotifsGenome.pl from HOMER using the 






CHAPTER IV  
DISCUSSION, SUMMARY, AND FUTURE DIRECTIONS  
 
Mechanisms controlling rhythmic transcription 
In mammals, CLOCK: BMAL1 regulates gene expression rhythmically and it is assumed 
that this regulation is necessary and sufficient to drive rhythmic expression of genes needed for 
biological processes. However, gene expression associated with CLOCK:BMAL1 cistromes is 
highly heterogenous 7,12,83. We suggest that this heterogenous genes expression is not due to 
nonfunctionally binding of CLOCK:BMAL1, but that the regulation of gene expression of 
CLOCK:BMAL1 targets relies on much more complex mechanism. This hypothesis is further 
supported by the finding that 82.2% of protein coding genes found in the Baboon were found to 
be rhythmic in at least one tissue, again suggesting that regulation of rhythmic expression relies 
on more than just CLOCK:BMAL1 binding  195. This issue lead to the question of whether 
CLOCK:BMAL1 binds in a tissue specific manner to control tissue specific rhythmic gene 
expression. This tissue specificity of regulation of rhythmic gene expression suggest that the 
binding of CLOCK:BMAL1 is not the same in every tissue and that regulation of gene expression 
is more complicated than CLOCK:BMAL1 activation. Furthermore, full body knockouts of 
BMAL1 exhibit a distinct change in expression of genes; genes are either found to be up-regulated 
or down-regulated. This suggests that CLOCK:BMAL1 do not activate expression, but recruit 
other transcription factors to regulate expression of target genes possibly in a tissue specific 
manner.  
We proposed in chapter II that CLOCK:BMAL1 rhythmically promotes permissive 




repress transcription. Additionally, that this poised enhancer is what is need for the body to adapt 
to environmental changes and is how the circadian clock controls rhythmic biological processes 
needed for particular times of the day. Furthermore, this suggest a mechanism of how disruption 
of the circadian clock leads to many different biological diseases because without these primed 
enhancers the cell cannot activate transcription fast enough to respond to a stimulus.  
Additional work has been done in our lab to further confirm that CLOCK:BMAL1 promote 
a transcriptionally permissive landscape by characterizing BMAL1 cistrome in three different 
tissues 196. This data illustrated that BMAL1 binds tissue specifically with other ts-TFs and that 
tissue specific expression of target genes relies on interactions with other TFs. Again suggesting 
that the binding of CLOCK:BMAL1 is to promote a permissive enhancer and not to activate 
transcription. Furthermore, many of the areas where BMAL1 was binding in a tissue specific 
manner were considered to be open chromatin in all three tissues 196. This data suggests that 
BMAL1 is not a pioneer transcription factor and instead prevents DNA from rewrapping around 
nucleosomes with the help of ts-TFs 13,196. Furthermore, this suggests a way in which the cell 
autonomous circadian clock regulates biological process in a tissue specific way.  
Transcription is regulated in many different ways by many different proteins. Traditionally, 
transcription factors bind to enhancers and recruit additional TFs, PIC, and the Mediator to activate 
transcription 14,21. We have observed that CLOCK:BMAL1 appears to bind with other ts-TFs and 
recruit in ub-TFs to activate or repress transcription. However, little is understood of how these 
TFs interact with the PIC and the Mediator. One study has been able to link CLOCK with the 
Mediator (MED1) through the interaction of TRAP150 (thyroid hormone receptor-associated 
protein-150) 197. They observed that TRAP150 bridged the gap between CLOCK:BMAL1 and the 




Furthermore, they suggest that this interaction with TRAP150, which is rhythmically regulated, is 
critical to coordinate rhythmic transcription by linking CLOCK:BMAL1 to basic transcriptional 
machinery at genes driven predominantly by CLOCK:BMAL1 197. These findings suggest a way 
in which CLOCK:BMAL1 coordinates core clock gene expression, but still leaves to question if  
CLOCK:BMAL1 interact with the PIC and Mediator on a genome wide level. 
Additionally in chapter II we suggest that it may be possible for CLOCK:BMAL1 to 
mediate long-range chromatin interactions. We observed an enrichment of the CTCF transcription 
factor motif at genes that were non-expressed and found that enhancers targeting the same gene 
exhibited similar transcriptional activity profiles. To address whether it was possible for 
CLOCK:BMAL1 to mediate these long-range chromatin interactions, a PolII ChIA-PET 
(Chromatin Interaction Analysis by Paired-End Tag Sequencing) experiment was conducted at 
ZT6 and ZT18 to identify interactions of DHSs for genes undergoing active transcription 196. This 
experiment identified that many CLOCK:BMAL1 sites interacted with other DHSs and that these 
interactions were higher at ZT6, the time of maximal CLOCK:BMAL1 DNA binding. 
Furthermore, many of these interactions at ZT6 were for genes that were found to be expressed 
rhythmically in-phase (Rinφ) with CLOCK:BMAL1 DNA binding. This suggests that 
transcription of these genes relies on CLOCK:BMAL1 coordinating a permissive chromatin 
landscaping of their enhancers. However, this experiment needs to be done in a BMAL1 knockout 
to verify this hypothesis.  Additionally, many of the AR genes showed CLOCK:BMAL1 DHSs  
interacting with many other DHSs, suggesting that temporal control of transcription may rely more 
strongly on the activity of the TFs binding in DHSs without CLOCK:BMAL1. Furthermore, Ro/φ 
genes showed an enrichment for Rev-erbα, a core clock repressor transcription factor. A recent 




with circadian gene expression 198. This study found that Rev-erbα bound enhancers recruited in 
histone deacetylases, evicted elongation factors BRD4 and MED1, and opposed chromatin looping 
198. This data Altogether further suggests that chromatin looping is occurring to help coordinate 
rhythmic gene expression and that regulation maybe occurring around CLOCK:BMAL1 
enhancers.  
Altogether this suggests that the circadian clocks transcriptional mechanisms are complex 
and multilayered. The pervasive circadian regulation of biological processes are intimately linked 
to regulation of physiologies, requiring gene expression to coincide with metabolic demands to 
optimize energy utilization 7,199. Our analysis and those done by others, suggests ways in which 
the dynamic circadian clock may adapt to an ever-changing environment. 
 
Disruption of the circadian clock leads to disease 
 In mammals, the circadian system is a collection of cell autonomous biological clocks that 
are all synchronized by the SCN 5. This master circadian clock is synchronized by light:dark cycles 
and sends signals to the rest of the peripheral clocks by controlling body temperature, feeding 
behavior, and hormone releases 5,33. Disruptions of light:dark cycles or any of the signals sent by 
the SCN to the rest of the body has been correlated to many different diseases 40,200,201.  
Shift work requires people to work outside the normal 9am to 5pm schedule and causes 
people to be exposed to many alter light:dark cycles, changes in body temperature, altered feeding 
behaviors, and changes in hormone releases 35. Additionally, many of diseases such as metabolic 
disease, cardiovascular disease, and cancer have been correlated with shift work and it has been 




  Many studies have been done to try and understand the mechanism of how shift work 
causes disease. Population-based studies are problematic because humans have to many outcomes 
that are long-term, as well as too much variation in lifestyle between each individual 35,39,202. 
Therefore, an animal model is preferred and has been used to try and investigate the mechanisms 
that underly the diseases correlated with shift work.  
Multiple studies done by our collaborators aimed at addressing how shift work causes 
metabolic disorders. They did this by forcing male Wistar rats to stay active during their rest phase 
and had different groups altering time of food availability, because food consumption is known as 
being a very important synchronizer of the peripheral clocks and that changes in time of food 
intake has led to metabolic disorders 143,190,203. Additionally, shifting the time of food intake is very 
characteristic feature of shift workers 35. In this study they found that even the Control rats, who 
did no amount of shift work but had food restricted to their rest phase, during the day, exhibited 
an increase in bodyweight and fat accumulation compared to ad libitum or night fed Controls 
181,190. Furthermore, they observed that the phase of the molecular circadian clock altered in the 
liver changed according to when the rats were fed, and that obesity and diabetic symptoms could 
be inhibited by time of feeding 36,204. These findings suggest that it is the time of food intake and 
not shift work that leads to metabolic disorders.  These findings raise the question of whether the 
act of shift work causes health disorders or if it is the changes in signals that desynchronizes the 
peripheral clocks.  
 In chapter III we aimed to investigate the molecular mechanisms by which shift work and 
or food consumption contribute to cardiovascular disorders. We found that five consecutive weeks 
of shift work Monday-Friday was enough time to increase collagen deposition in the hearts of both 




gene expression for Worker Restricted Feeding rats compared to Controls and Workers. This was 
surprising because eating during the normal active phase was enough to prevent metabolic 
disorders and a shift in the circadian clock in the liver 36. Therefore, since we observed an increase 
in collagen deposition in both the Workers and Worker Restricted Feeding rats, this suggests that 
the desynchrony caused by food consumption is not causing an increase collagen deposition.  
Furthermore, we did not observe a shift in the expression of molecular circadian clock in 
the heart for Worker Restricted Feeding rats compared to Control rats (data not shown), however 
we still observed an increase in collagen and significant changes in gene expression. This data 
suggests that desynchronization of the molecular circadian clock in the heart is not needed to cause 
an increase in collagen deposition or up-regulation of profibrotic gene expression.  This suggests 
that these changes may actually be caused by doing shift work and not a desynchronization of the 
molecular circadian clock in the rat heart.  
Food consumption is not the only signal altered when these animals do shift work. These 
rats are also forced to stay awake during the day and are thus exposed to light and the stress of 
being forced to stay awake out of synchronization with their natural wake and sleep cycle. Many 
studies have indicated a positive correlation between stressors and corticosterone levels 37. 
Furthermore, corticosterone observed in rats forced to do shift work has a biphasic peak, one when 
the rats are forced to work and the second just as lights turn off 181,190. This peak just as the rats are 
forced to do shift work suggests that these rats do experience stress and that this may be playing a 
role in the collagen deposition observed in Worker and Worker Restricted Feeding rat hearts. 
Additionally, the stress of shift work may be causing a heightened activation of the sympathetic 
nervous system enhancing the adrenergic signaling pathways via catecholamines, norepinephrine, 




been associated with triggering cardiovascular disease and unless treated has been known to 
progress to heart failure 205,206. However, this hypothesis that shift work is causing a heightened 
activation of the adrenergic signaling pathway in shift working rats will need to be validated. 
Additionally, in Chapter III we discussed that the TGF-β, ErbB, INSR and GLUT pathways 
activate fibroblast that can lead to fibrosis and cardiac failure in the heart 51,154,168,169. However, 
even though we observed an increase in collagen deposition, we observed very little changes in 
gene expression associated with these pathways in Worker and Worker Restricted Feeding rats. 
These results suggest that regulation of these pathways occurs at the protein level and that future 
work such as proteomics should be done to address possible changes caused by shift work.  
Our analysis, is the first to correlate shift work, regardless of the time of eating, with an 
increase in collagen deposition in the heart. Altogether this suggests that shift work can cause 
desynchronization at many different levels and that gene expression alone is not sufficient to 
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